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A known bidirectional relationship between intestinal microflora and the central 
nervous system, coined the gut-brain-axis, has stimulated work on the association 
between gut dysbiosis and inflammation, and sleep quality. Previous studies in the Hayes 
Lab have reported that a high fat (HF) diet was correlated with immobile phases, a 
marker of low motility during sleep found in some neurological disease and sleep 
duration[1]. Long sleep duration (>1 S.D. above norms for age) is associated with poor 
sleep quality or sleep fragmentation in participants who are overweight or obese 
according to body mass index values[2]. The current work utilizes  a reverse translational 
model to propose that we can identify some of the molecular mechanisms underlying 
consumption of a HF diet and sleep fragmentation. The animal model for the current 
study was Danio rerio, or zebrafish. Within this Honors Thesis, an existing protocol for 
Danio rerio sleep analysis was modified in order to assess the correlation between 
inflammatory pathways induced via direct infection by the human fungal pathogen 
Candida vs. HF diet-induced gut dysbiosis  on developed measures of sleep quality[3]. 
Sleep analysis was administered via a Noldus DanioVision behavioral tracking device 
and showed that, in 80% of replicate experimental trials (n=86), infected zebrafish larvae 
exhibited increased total sleep duration, sleep % and mean sleep bout length. In 60% of 
replicate experimental trials (n=68), infected zebrafish larvae exhibited a greater number 
of sleep bouts, a finding consistent with sleep fragmentation defined as the number of 
sleep bouts divided by the total sleep duration. Sleep analyses conducted for diet-
controlled larvae showed that zebrafish larvae administered a high fat diet exhibited an 
 
 
increase in sleep bout number and larger fragmentation index, though this observation 
was not found to be trending or statistically significant. Zebrafish were euthanized and 
homogenized following sleep analysis in order to be used for single fish qPCR. In 
Candida infected larvae, gene expression of multifunctional pyrogenic and somnogenic 
cytokines TNF-ɑ and IL-6 were upregulated according to -ΔΔCt values which are 
calculated as the negative difference of the ΔCt of each individual treated larvae and the 
average ΔCt value of each control, non-treated larvae. Similarly, in HF diet-treated 
larvae, gene expression of IL-1β and IL-6 was also elevated. Positive gene fold 
expression was  elevated for IL-6 in both infected and HF diet treated zebrafish. These 
findings suggest that a mutual inflammatory pathway, triggered via direct infection or 
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Sleep Physiology and the Molecular Clock 
 
Sleep is defined as a behavioral state consisting of immobility and depressed 
responsiveness, both of which may be quickly reversed during the transition from sleep to 
wakefulness[4]. While it is unclear if all animals sleep, all higher eukaryotes not only 
exhibit regular sleep states, but also require sleep for proper maintenance of physiological 
processes[4]. Though sleep, a homeostatic phenomenon hypothesized to result due to the 
daily accumulation of adenosine primarily in the basal forebrain should not be confused 
with the distinct mechanism of circadian rhythm, a physiological ‘molecular clock’ which 
regulates higher eukaryotes to a 24 hour oscillatory cycle entrained to light-dark cycles 
via the suprachiasmatic nucleus or SCN[5, 6]. In fact, sleep-wake regulation is often 
described as a ‘two-process model’ defined by the homeostatic sleep promoting 
component (process S), which accumulates due to physiological energy expenditure and 
waste buildup throughout the day, and the circadian wake promoting component (process 
C) which serves to consolidate sleep periods and entrain sleep-wake states to light-dark 
cycles[7]. While a basic understanding of the neurophysiology underlying circadian 
rhythm and subsequent observable behaviors (i.e. nighttime sleep) is critical for 
understanding this project, this Honors Thesis is concerned with predicting homeostatic 




In humans, the foundation of the circadian rhythm (process C) begins in the SCN 
which has since been deemed the ‘pacemaker’ of the circadian clock[8]. In response to 
millions of years of evolutionary fine tuning, the SCN has become accustomed to daily 
environmental oscillations, such as sunlight and external temperature, such that it can 
regulate the body’s general metabolic and physiologic profile to match the demands of 
the time of day. While the SCN and other neuroanatomical structures regulate the 
molecular clock at a body-wide level, each cell within the body is home to its own set of 
tightly regulated transcription factors which mediate the individual oscillations at a 
molecular and tissue trophic level. The largest transcriptional contributors to this 
phenomenon, and subsequently the most well understood, are Circadian Locomotor 
Output Cycles Kaput, Brain and Muscle Arnt-like 1, Period, Cryptochrome, Reverse 
Erythroblastosis Virus ɑ, and Retinoid-related Orphan Receptor ɑ or CLOCK, BMAL1, 
PER, CRY, REV-ERBɑ, and RORɑ, respectively[9]. While the roles and regulatory 
mechanisms of these genes and their encoded polypeptide products are quite intricate, 
their general function in maintaining circadian oscillations can be summarized quite 
simply. In short, proteins BMAL1 and CLOCK are known to dimerize and directly 
upregulate transcription of both PER and CRY. Following translation, PER and CRY are 
known to associate and re-enter the nucleus to then depress expression of their activators 
BMAL1 and CLOCK. Moreover, REV-ERBɑ serves as a transcriptional repressor for 
BMAL1 expression and RORɑ acts as a transcriptional activator[10,11]. In this manner, 
the core of the cellular molecular rhythm is regulated by BMAL1 and CLOCK which are 
externally regulated by REV-ERBɑ and RORɑ and internally regulated by their own 




and repressed, the levels of PER and CRY oligopeptides gather within the cytoplasm and 
enter a complex signaling pathway resulting in melatonin production[12]. Thus, the core 
set of 6 proteins described above regulate the oscillation of melatonin, a critical 
somnogenic hormone, as well as a wide array of other hormone and protein 





Circadian Regulation of Metabolism, Neural Phenomena, and Immune Activity 
 
In addition to the melatonin-mediated sleep regulatory pathways discussed above, 
the cellular molecular clock system is also known to regulate general metabolic and 
physiological pathways involved in recovery, regeneration, and synthesis[13,14,15]. 
Perhaps the most well understood role of sleep in physiological development and 
restoration is the differentially observed release and fluctuation of circulating hormones. 
Specifically, growth hormone release, or the pulse of most anabolic hormones (e.g. 
testosterone and prolactin) for that matter, occurs during slow-wave sleep (SWS)[3]. In 
addition to this, catabolic hormone release (e.g. cortisol) is depressed during sleep states. 
Such restorative and growth oriented hormone release, coupled with the decreased energy 
demand during sleep, lends human sleep states (i.e. the result of process S described 
above in which the homeostatic driver of sleep induces immobility and depressed 
responsiveness) to play a necessary role in maintenance and regeneration.  
In addition to endocrine associated bodily regeneration[14], the significance of 




amyloid, is well documented. For example, Xie et al reported that cerebrospinal fluid 
fluxes upregulated during sleep elevated clearance of β-amyloid, a waste product which 
accumulates as a result of typical neural function during the day[15]. Conversely, a key 
pathological finding of Alzheimer’s Disease is excessive buildup of β-amyloid plaques 
and previous studies have shown that even Alzheimer’s Disease patients have both 
elevated β-amyloid and circadian fragmentation as compared to cognitively normal 
individuals[16]. Both in age-related neurodegenerative diseases and in healthy 
individuals  the importance of sleep in learning and memory has been extensively 
studied. For example, previous studies from the Walker group indicate that a full night’s 
sleep yielded elevated motor learning and, in some instances, even properly timed naps 
were able to produce similar results[17]. Furthermore, related research has supported that 
an increase in nighttime sleep is correlated with learning efficiency, memory 
consolidation, and other neurological metrics associated with learned 
performance[18,19]. Complex experimental methods have reported direct correlations 
between sleep deprivation and impaired hippocampal-dependent learning suggesting that 
routine quality sleep is critical for neurogenesis, memory encoding, and spatial 
learning[20,21].  
Most pertinent to this presented study is the interplay of the immune response and 
sleep loss. Specifically, even acute sleep loss (25-50% of a single 8 hour nightly sleep 
routine) has been shown to elevate basal inflammatory cytokine expression[22]. 
Moreover, many cytokines have been shown to hold somnogenic and pyrogenic 
properties meaning that they are involved in sleep as well as the pro-inflammatory 




interleukin-1β (IL-1β), and interleukin-6 (IL-6), are all generally classified as 
proinflammatory proteins though differential expression of these cytokines is tightly 
associated with sleep. For example, all three proinflammatory signaling molecules are 
expressed at higher levels during sleep[23]. Similarly, anti-inflammatory cytokines which 
serve to downregulate the pathways activated by TNF-ɑ, IL-1β, and IL-6 are upregulated 
during waking states and may even perturb the transition into sleep states[23,24]. 
Moreover, inhibition of IL-1β has been shown to induce sleep deprivation and decreased 
sleep rebound[23] and increased TNF-α expression has been linked to upregulated sleep 
duration[25], especially following infection[26]. To complement these associative 
findings, extensive work has been done in the field of chrono-immunology or the study of 
how circadian rhythms play a reciprocal role with immune activity. One such study found 
that in mutant mice strains with defective CRY genes, the repressor of BMAL1 and 
activator of melatonin production described above, a more aggressive pro-inflammatory 
signaling response downstream of TNF-ɑ activation was observed[27]. Finally, related 
publications report that even Rev-erbɑ partial knockdown (or deficiency) perturbs the 
oscillations of IL-6 production and knockdown or CRY2 upregulates the production of 





Sleep and Circadian Disruption as a Drive of Disease 
 
Sleep is necessary for proper bodily function, particularly as it pertains to 




quickly lead to various pathological states. For example, patients with gastroesophageal 
reflux disease (GERD) who become sleep deprived due to any number of social or 
environmental factors have been reported to experience exacerbated pain and discomfort 
GERD symptoms[30]. Previous work indicates that obstructive sleep apnea (OSA) is 
known to induce, or at least worsen, hypertension[31]. Further, Porto and colleagues 
(2017) reported that extreme cases of OSA can even lead to myocardial infarction [32]. 
Interestingly, sleep deprivation can even lead to differential immune system function in 
pathological conditions. One example of this was reported by Palma and colleagues 
(2006) who suggested that sleep deprivation in mice models could induce early onset 
symptoms resembling the human autoimmune disease systemic lupus erythematosus[33]. 
Thus, disrupted sleep quality and circadian rhythm can, quite literally, cause the body to 
become accustomed to dysregulated immune function and self-harming pro-inflammatory 
signaling cascades. Preliminary results reported by Hayes et al.,2018, who examined the 
association between sleep fragmentation (defined as the sum of percent mobile and 
percent one minute immobile bouts divided by the number of immobile bouts during a 
sleep interval) and mild cognitive impairment in aging adults, are consistent with 
previous findings that age-related neurodegenerative diseases and both actigraphic and 
self-reported sleep loss are common[34, 35]. 
 
 
Disease as a Driver for Disruption of Sleep and Circadian Rhythm 
 
 
The observation that sleep disruption may serve as a driver for human disease is 




immune regulation are reciprocally regulated by oscillatory rhythms, many disease states 
are known  to disrupt sleep and circadian rhythms[36, 37]. For example, previous studies 
have shown that various cardiovascular disorders may lead to disrupted circadian rhythm 
and associated symptoms[38]. Similarly, hypertension has been shown to dysregulate the 
circadian rhythm of natriuresis[39]. Most well studied, and most pertinent to this Honors 
Thesis, is the impact of age-related neurodegenerative disease on sleep and circadian 
rhythm. Namely, previous studies on the pathophysiological mechanisms of Alzheimer’s 
Disease (AD) as well as the clinical prodrome of AD, Mild Cognitive Impairment (MCI), 
have determined that sleep and circadian rhythm disorders in MCI are common[40]. 
Related work has shown that  aging persons with Alzheimer’s display sleep disruption 
associated with  elevated daytime sleepiness, elevated sleep duration, and elevated sleep 
fragmentation and individuals with MCI show profound sleep disturbances[41,42,43]. 
Given that MCI is defined as cognitive impairment that is not severe enough to impede 
daily functioning, often the earliest neuropsychiatric herald of MCI is poor nighttime 
sleep especially in both amnestic and non-amnestic MCI individuals[44, 45]. In 
particular, sleep fragmentation has been characterized as both a risk factor and a 
diagnostic metric for MCI which, as described below, would serve as the foundation 














Alzheimer’s Disease, Mild Cognitive Impairment, and Sleep Disruption 
 
Alzheimer's Disease (AD) composes 50-70% of dementia cases in North 
America[46]. It is projected that, by 2050, the global prevalence of AD will reach 106.4 
million[47]. Mild cognitive impairment (MCI), amnestic type is a precursor disease to 
AD which presents as having cognitive decline which does not impede daily function 
[48]. Demographic and lifestyle factors including socioeconomic status, education, 
gender, and depressive symptoms have been correlated with MCI and ADRD disorders 
[34]. Amnestic MCI transitions to ADRD (Alzheimer’s disease and related dementias) in 
80% of cases within 6 years, developing novel methods of early detection at early stages 
is needed, as less than 40% of positive cases are identied in primary care or referred to a 
specialist. Sleep loss is an early sign of cognitive impairment and developing MCI in 
community dwelling aging adults[40]. Holtzman et al. proposes a bidirectional 
relationship between sleep continuity, particularly, stage 3 and 4 NREM, and amyloid 
and tau clearance that is widely supported by human and animal model findings as a 
potential mechanism for the role of sleep disorder in MCI/ADRD development[49]. 
Typically, diagnosing sleep fragmentation as a means of primary prevention for MCI 
requires the use of an overnight clinical sleep laboratory which is uncomfortable for 
aging patients, costly and often yields poor results. The Hayes Lab has developed a 
patented sleep recording mattress device that can be used in the home bed for detecting 
sleep-wake and respiratory patterns[34, 50]. 
The diagnostic utility of the sleep recording device is compared to FDA approved 




movements and activity levels. Since then, computational analyses and algorithms have 
been optimized to characterize not only sleep and wakefulness but various sleep 
parameters including fragmentation indexes[51]. Within the context of the clinical trial, 
participants were acquired either by physician referral or community recruitment events. 
Each participant was then subjected to a 1 week at-home clinical sleep study consisting of 
sleep analysis, neurocognitive assessment, and a wide range of exploratory statistical 
analyses to elucidate other moderators of sleep quality such as dietary habits. On day 1 of 
the study, participants were administered a battery of neurocognitive assessments to be 
used for the physician diagnosis of neurotypical status, MCI, or AD and set up with both 
the home-mattress sleep recording device as well as the aforementioned Actiwatch 
positive control device. The sleep recording device and Actiwatch were picked up on 
days 3 and 8 of the study, respectively, and all neurocognitive and demographic metrics 
were compiled and assessed as potential moderators of any differential sleep variables 
observed between neurocognitive healthy aging participants and MCI or AD participants.  
It was hypothesized that greater actigraphic sleep fragmentation would be associated with 
MCI and AD in aging individuals. In addition to this, a pilot study was conducted which 
aimed to identify the power of dietary habits as a moderator of sleep quality.  The 
primary function of the novel sleep recording device  is to identify early MCI/ADRD in 
community dwelling adults using machine learning methods[52]. MCI-like sleep features 
showed chronic sleep fragmentation due to increased frequency and duration of wake 
after sleep onset, WASO), a finding supported by actigraphic findings in our sample and 
consistent with the MCI/ADRD literature. The two night at-home sleep analysis included 




known moderators of sleep quality which have been previously symptomatic of age-





Western Diet and Sleep Quality in Aging Adults 
 
In my Honors Thesis, I was particularly intrigued by the question of the impact of 
diet on cognition and AD. The specific mechanism is discussed in further detail below 
and in Figure 1 but, in brief, diet and aging have been associated with upregulated 
inflammation correlated with perturbed dendritic plasticity, altered neurotransmitter 
levels, and cognition[53]. As such, it is critical that more work be done to elucidate the 
molecular connection between nutritional intake and potentially-pathogenic inflammatory 
pathways. Specifically, little is currently known about the impact of Western Diet, 
characterized by high fat and sucrose intake (e.g. pre-packaged foods and high-fat dairy 
products) as well as low fiber consumption, on sleep quality in aging adults[54]. In this 
Honors Thesis, a self-reported dietary survey was administered to patient’s already 
undergoing an at-home sleep study in order to attempt to identify an association between 
diet and MCI or AD-related sleep disruption. This pilot study was conducted on a subset 
of the participant population (n=13) who were administered The Dietary Fat and Free 
Sugar - Short Questionnaire (DFS)[55]. The DFS is a participant self-reported dietary 
questionnaire consisting of 26 scale ranked questions. Each question on the DFS pertains 
to the frequency of consuming certain foods, particularly those high in fat or free sugar. 




score. Previous studies have optimized the DFS such that the total score can be used to 
place participants into one of two categories[55]. Participants who score less than 60 on 
the DFS are categorized as having nutritional intake within the World Health 
Organization’s (WHO) recommended levels while participants who score greater than or 
equal to 60 on the DFS are categorized as having fat and sugar intake above the WHO’s 
recommended levels. The DFS was administered on Day 1 of the one week at-home sleep 
study in order to place participants into ‘Fat and sugar intake within recommended level’ 
or ‘Fat and sugar intake above recommended level’ groups. It was hypothesized that 
participants who were placed into the ‘Fat and sugar intake above recommended levels’ 
group would display perturbed sleep quality, more consistent though not necessarily 
correlated with that of MCI and AD individuals than cognitively healthy individuals, as a 
result of gut-dysbiosis induced inflammation. Discussed further in the Results Section, 
the results of statistical analyses suggest that a diet consisting of high fat and sugar 
content is correlated with a greater mean number of immobile phases and longer sleep 
duration in aging adults suggesting that adults who consumed a Western Diet had more 






Western Diet-Induced Gut Dysbiosis and Immune Disruption 
 
 While there are extensive social factors which may have mediated the association 
between poor diet and disrupted sleep quality (i.e. duration and immobility) in aging 




mechanism could connect the two behaviors. In particular, this correlation could be a 
result of gut dysbiosis and the gut-brain-axis.  
It is estimated that, in every 1 gram sample of human gut tissue, there lives ~ 1011 
bacterial cells[56]. It is well known that this bacterial population, commonly referred to 
as human gut microflora, participates in extensive intracellular signalling pathways which 
are necessary for human health. In particular, individuals with healthy immune systems 
display a diverse gut microflora population which is critical for nutrient metabolism, 
digestive health, and immune response communication[57]. Furthermore, gut microflora 
have also been shown to play a key role in systemic signalling cascades which may travel 
as far as the human central nervous system (CNS)[58]. Previous studies have shown that 
gut microflora are involved in CNS-related protective pathways which inhibit the 
symptoms of depression and anxiety[59]. Alternatively, various neurological disorders 
have also been shown to negatively impact gut microbiota-involved processes such as 
epithelial permeability and pathogen defense[60]. This bidirectional relationship between 
human gut microflora and the brain has been coined the gut-brain-axis (GBA).  
Given that the human gut microflora and central nervous system are so tightly 
intertwined, it should come as no surprise that disrupting one’s microbial gut health by 
consuming a poor diet can lead to damaging neurosignaling cascades. An example of this 







Figure 1. Schematic depicting how Western diet induces gut dysbiosis, systemic 
inflammation, and neurological pathology. (1) The mice is shown eating a cupcake, 
representative of a high fat and sugar diet, which alters the typical microflora of the gut 
as only select ‘good bacteria’ can survive on such poor nutritional intake and some ‘bad 
bacteria’ or opportunistic pathogens invade the inhabitable epithelia. (2) As this occurs, 
there is an overall change in the biochemical profile of the gut including alterations such 
as depressed levels of short chain fatty acids among others. (3) As commensal bacteria 
cells die, they release endotoxins stored within their lipopolysaccharide layer which are 
absorbed through the intestinal epithelium, triggering an immune response. (4) As a 
typical component of the acute phase response, pro-inflammatory cytokines are released 
to recruit immune cells to the gut. (5) These pro-inflammatory cytokines are not gut-
tissue trophic and can travel via the blood brain barrier to the central nervous system. (6) 




inflammatory signal cascade induction, which leads to a diseased state. Figure published 
by Noble et al., 2017). 
 
 As described above, a key characteristic of high fat diet fed mice is depressed 
levels of short chain fatty acids (SCFAs) which are produced as a byproduct of bacterial 
metabolism as many commensal microbes ferment carbohydrates that cannot be digested 
by host cells. These microbial produced SCFAs (e.g. butyrate) mediate development of 
regulatory T cells in the gut which are necessary for mitigating intestinal inflammation. 
Furthermore, these same SCFAs have been shown to bind to specific G protein coupled 
receptors on the surface of neutrophils to perturb their crossing into the intestinal 
epithelium which results in inflammation. As such, previous studies have shown that just 
high fat diet consumption can alter gut microbe inhabitants in a manner that limits the 
amount of inflammation-preventing fatty acids, thereby leading to gut-dysbiosis induced 
inflammation[62]. Further, related research has found that such SCFA-mediated T cell 
development may serve as the tipping point for polarization of naive T cells towards T 
regulatory cells or Th1 and Th17 cells. In addition to this, SCFAs have also been shown 
to inhibit pro-inflammatory markers (e.g. TNF-ɑ and IL-6) in macrophages[63]. As a 
result, depressed levels of intestinal SCFAs tend to elevate pro-inflammatory cytokine 
expression, elevate pathogenic T helper cell presence, and suppress T regulatory cell 
presence which was found to induce central nervous system inflammatory cell 
infiltration, elevate demyelination, and promote axonal damage[64]. 
 
 In concordance with the hypothesized mechanism described above which explains 




development, and disrupted CNS maintenance, related work by Lee et al., (2017) further 
characterized the impact of an obesogenic diet on differential gut microbial inhabitants 
and subsequent impaired gut immune health. In this study, Lee and colleagues fed mice 
model groups with a normal chow diet or a high fat diet before various histological, cell 
culture, and molecular methods were used to identify the putative harmful effects of a 
Western diet. Beginning with the histological changes, Lee and colleagues observed that 
high fat diet treated mice contained morphologically altered Paneth cells, which line the 
intestinal epithelium in the small intestine and regulate commensal microbe growth via 
secretion of antimicrobial peptides. Moreover, the remaining Paneth cells in high fat diet 
treated mice contained less eosinophilic granules and produced less lysozyme and 
procryptidin, among other antimicrobial peptides (e.g. Defcr1). Furthermore, Lee and 
colleagues also identified via confocal microscopy and RT-qPCR methods that high fat 
diet treated mice had less goblet cells within the interstitial epithelia and subsequently 
produced less mucin, a key protein involved in the maintenance of the epithelial mucus 
membrane which binds to various gut microbes in order to prevent their crossing of the 
epithelial barrier. Such epithelial crossing by immune cells, as well as bacterial 
lipopolysaccharide (i.e.bacterial translocation) has been further shown to upregulate pro-
inflammatory markers such as (TNF-ɑ, IL-1, and IL-6) in the gut and other tissues (e.g. 
liver and pancreas)[65]. Finally, 16s rRNA analysis identified that high fat diet treated 
mice had a greater abundance of Firmicutes and Actinobacteria as well as depressed 
levels of Bacteroidetes. In this manner, Lee and colleagues observed that a high fat diet 
altered the intestinal epithelial cell profile, particularly in cells involved in commensal 




layer-producing goblet cells, perturbed the barrier function of the gut, and directly altered 
the presence and abundance of select gut microbes. As such, previous work suggested 
that mice treated with a high fat diet experience gut-dysbiosis associated with altered gut 
microbiota and intestinal immune health which has been known to induce altered immune 
cell differentiation, epithelial barrier function, and even central nervous system 
activity[66]. 
While the phenomenon described above of Western diet induced gut dysbiosis 
links together an obesogenic diet, altered gut microbiota presence, immune activity, and 
CNS function, no studies to date have defined how this mechanism may directly impair 
sleep quality. The clinical observation which supported that individuals who consumed 
diets high in fat and free sugar showed a greater mean number of immobile phases and 
sleep duration, could be an empirical example of the phenomenon described in Figure 1 
and highlighted in the studies discussed above. Thus, the human sleep data generated for 
MCI and cognitively normal participants raised a question of the physiological 
mechanism connecting poor diet to disturbed sleep quality in aging adults. In order to 
examine this question in a tractable vertebrate experimental system, zebrafish were 
















Zebrafish as a Model Organism 
 
Zebrafish are cyprinoid teleosts which are quickly becoming a popular model 
organism for biomedical research[67]. In addition to being cheap to purchase, zebrafish 
husbandry and aquarium spawning is relatively simplistic. Though they can begin eating 
as early as 3 dpf, zebrafish larvae do not need to be fed for long-term survival until 4 dpf, 
allowing researchers to save time and money on general maintenance and husbandry[68]. 
In addition to this, adult zebrafish can spawn in under 24 hours allowing for researchers 
to rapidly collect fresh larvae even multiple times a day. In regards to molecular 
experimental methods, as it pertains to this study, the zebrafish and human genomes 
share 71.4% homology, particularly in regards to the innate and adaptive immune 
system[69]. As such, zebrafish can be used as safe alternatives for genome editing 
analyses in order to model human disease and pathogenesis. In addition to this, mutant 
zebrafish strains with pre-determined genetic mutations (e.g. TNF-ɑ knockdown) are 
commercially available. Zebrafish larvae are also naturally transparent until about 5 dpf 
which is useful for various microscopy, injection, and fluorescence-based assays[67]. 
Thus, this model organism is perfectly suited for modeling reverse translational research 




Zebrafish as a Model Organism for Sleep Analysis 
 
In mammalian species,  two distinct categories of sleep have been identified: 




Interestingly, zebrafish and humans both share nearly identical sleep ontogeny profiles 
conserved through evolution[3]. Similarly, in both humans and zebrafish, as age increases 
sleep percentage decreases. With regard to other common sleep variables, including sleep 
percentage, sleep bout length, sleep bout number, and fragmentation, zebrafish and 
humans show similar results. However, while sleep-wake transition counts do not 
necessarily decrease as humans age, they do decrease in aging zebrafish[3]. Thus, 
zebrafish larvae are likely the best model for reverse translational research examining any 
sleep human sleep variable as they are the most comparable in regards to overall sleep 
ontogeny. Finally, much like humans, zebrafish sleep quality has been shown to be 
impacted by environmental factors including temperature and light changes[70]. Thus, 
zebrafish circadian rhythm can be entrained under desired lab control conditions in ways 
that would not be possible with human participants, allowing for analysis of moderators 





Zebrafish as a Model Organism for Immune Response Analysis 
 
As discussed above, zebrafish have become a popular model for general 
biomedical research as their genomes can easily be mutated to model human disease, they 
mate rapidly to produce large spawn batches, and have high genomic homology to 
humans[71]. Moreover, by 4 days post fertilization (dpf), zebrafish larvae exhibit fully 
robust T and B cell development which contributes to adaptive immunity[72]. Prior to 




experimentation. In addition to such professional immune cells, immune signaling 
cytokine messengers serve homologous functions in both humans and zebrafish. 
Specifically, the pyrogenic and somnogenic cytokines most pertinent to this study, TNF-
ɑ, IL-1β, and IL-6, are mutual between humans and zebrafish[73]. Zebrafish larvae have 
been used extensively as a model organism for fungal infection analysis, including that of 
Candida with previous research indicating that Candida infection upregulates TNF-α and 
IL-1 production as observed in humans[74,75]. Thus, zebrafish are a suitable candidate to 






Zebrafish as a Model Organism for Dietary Habits and Diet-Induced Gut Dysbiosis 
 
 Zebrafish larvae can be fed as early as 3 dpf with required feeding beginning at 5 
dpf[68]. The impact of various dietary profiles on zebrafish health has been extensively 
studied to model human nutrition and nutritional genomics[76]. In addition to this, 
following dechorionation at 1-2 dpf, zebrafish are exposed to the non-sterile environment 
which mediates the development of normal gut microflora colonization as the intestinal 
tract fully matures between 3-4 dpf. Thus, zebrafish have been used extensively to assess 
the impact of diet on gut-dysbiosis. Previous studies by Arias-Jayo and colleagues (2018) 
reported that a high fat diet induces gut microbiota dysbiosis as well as intestinal pro-
inflammatory signaling in zebrafish larvae[77]. Moreover, previous studies have also 




zebrafish, suggesting that such gut dysbiosis reported by Arias-Jayo and colleagues could 
lead to pro-inflammatory signaling-mediated central nervous system disruption[78]. 
Thus, zebrafish are a qualified model to assess the impact of a high fat diet on diet-
induced gut dysbiosis and subsequent sleep disruption in the current study.  In this 
Honors Thesis, it was hypothesized that zebrafish treated with a high fat diet would 
exhibit gut dysbiosis-induced inflammatory gene expression resulting in sleep disruption. 
The aims of this study are as follows: 
 
1. To determine if a high fat diet induces differential sleep quality, particularly as it 
pertains to fragmentation and sleep duration, in the common model organism 
Danio rerio, or zebrafish. 
2. To determine if direct infection by human fungal pathogen Candida albicans, 
proposed as an alternative method of mimicking the putative inflammatory state 
triggered by high fat consumption, induces sleep disruption in zebrafish. 
3. To determine if any differential sleep quality observed in zebrafish experiencing 
inflammation, be it by consumption of a high fat diet or direct infection, is 
correlated with elevated pyrogenic and somnogenic cytokine expression (i.e. 
TNF-ɑ, IL-1β, and IL-6). It is anticipated that Candida infection will induce 
greater sleep disruption than high fat diet administration due to stronger pro-









This Honors Thesis reports a reverse-translational study which assessed the 
impact of high fat diet and infection on sleep quality in zebrafish. The preliminary data 
reported within this Honors Thesis pertains to results I generated in a pilot study 
conducted within the MCI/ADRD ongoing study. In short, with Dr. Hayes’ assistance in 
amending the parent IRB, I was able to examine the correlation between Western Diet in 
MCI diagnosed participants and actigraphic sleep. In those data, sleep duration and 
immobility during sleep was positively correlated with DFS measure of high fat/high 
carbohydrate foods typical of the Western Diet. I hypothesized that in aging adults these 
sleep features were mechanistically linked to gut-dysbiosis induced inflammatory 
signaling. In order to address this hypothesis, a follow-up study was designed and 
conducted in zebrafish in order to identify if pro-inflammatory cytokine expression, 
induced via diet or infection, was a moderator of sleep duration and immobility. A trend 
for a correlation between Candida hindbrain infection, sleep disruption, and elevated 
TNF-ɑ and IL-6 gene expression was observed . Further, a trend for a correlation 














Participants of this study were acquired via community volunteers and physician-
diagnosed MCI patients. Each participant underwent a two-day sleep study followed by a 
one month follow-up neurocognitive assessment. For each sleep study, data was collected 
within each participant’s home utilizing a non-invasive sleep mattress device. This device 
is capable of collecting both respiration and movement data necessary to determine sleep 
fragmentation. Each participant was asked to maintain their typical sleep routine for the 
duration of the study. Participants within this pilot study (n=13) represent a group of 
individuals taken from the larger study described above (N=95). All participant 
interactions were approved by the UMaine Institutional Review Board for the Protection 





II. The Dietary Fat and Free Sugar - Short Questionnaire 
 
On Day 1 of the two-day sleep study, the Dietary Fat and Free Sugar - Short 




protocol developed by Francis and Stevenson, 201[55]. The DFS is a self-reported dietary 
questionnaire with 26 questions. The first 24 questions assess weekly intake of specific 
foods (e.g. pizza or chocolate.) The last two questions assess yearly take-out food intake 
and weekly free sugar intake. A copy of the DFS can be found in Appendix B. Each 
question is answered numerically 1-5 with a score of 1 indicating once per week or less 
and a score of 5 indicating five times per week or more. The total DFS score describes 
the sum of all answers 1-26 with a minimum total score of 26 and a maximum total score 
of 130. Francis and Stevenson, 2019 defined a total DFS score of 60 or greater as 
indicative of a total nutrient intake above recommended levels reported by the World 
Health Organization[55]. In addition to the DFS, demographic information and past 






III. Actiwatch and Activas Diagnostics Sensor Actigraphy Collection 
 
 All participants were subjected to sleep analysis by the UMaine Psychology and 
Engineering lab teams (PI: M. Hayes, PhD; A. Abedi, PhD) as well as a positive control 
actigraphy watch (Philips Respironics, Actiwatch 2) which had been previously approved 
by the American Academy of Sleep Medicine[74]. The non-invasive home sleep 
monitoring system developed by the UMaine teams utilized 32 sensors to record sleep 
movements and respiratory rate. In order to distinguish between brief whole-body 




sleep recording system consisted of both high weight (50 lb) and low weight (1 lb) 
sensors which were stacked on top of one another and adhered onto a typical cotton bed 
sheet in sixteen locations, totalling at 32 embedded sensors. In addition to recording two 
nights of sleep monitoring data using the UMaine sleep device, the actigraphy watch was 
worn by each participant for 7 consecutive nights. Each participant was instructed to wear 
the watch on their non-dominant hand at all times for the one week period aside from 
showering and certain activities which may have damaged the device. As opposed to the 
multi-sensor system utilized by the UMaine sleep device, the actigraphy watch coded 
sleep and wake states in 1 minute epochs through an accelerometer sensor located on the 
bottom of the watch. At the end of the one week period, the control actigraphy watch was 
collected by the UMaine teams and sleep/wake data was analyzed by an optimized 
program produced by the watch manufacturer (Philips Respironics, Philips Actiware 6: 
v6 0.9). 
 





Time in Bed Time elapsed between the start and end of the rest interval 
Assumed Sleep Time elapsed between the start and end of the sleep interval 
Actual Sleep Time The total number of epochs for the given interval scored as sleep by 
Actiware multiplied by the epoch length in minutes 
Sleep Percenta The percentage of epochs in an interval that are scored as sleep. 
Scored total sleep time divided by (interval duration minus total 
invalid time (sleep/wake)) multiplied by 100 
WASO/Wake Time The total number of epochs between the start time and the end time of 
a given interval (sleep) scored as wake by Actiware software 







Table 1 continued 
Wake Percenta The percentage of epochs in an interval that are scored as wake. 
Scored total wake time divided by (interval duration minus total 
invalid time (sleep/wake)) multiplied by 100 
Sleep Efficiency The percentage of time spent in bed sleep scored total sleep time 
divided by (interval duration minus total invalid time (sleep/wake)) 
multiplied by 100 
Sleep Latency The time required for sleep to start after initiating the intent to sleep. 
The time between the start of a given rest interval and the sleep 
interval start time, in minutes, and is controlled by the sleep interval 
detection algorithm 
Sleep Boutsa The total number of continuous blocks of epochs where each epoch is 
scored asl sleep for the given time interval (sleep) 
Wake Boutsa The total number of continuous blocks of epochs where each 
consecutive epoch is scored as wake for the given interval (sleep) 
Sleep Bout Timea The scored total sleep time divided by the number of sleep bouts for 
the given interval (sleep) 
Wake Bout Timea The scored total wake time divided by the number of wake bouts for 
the given interval (sleep) 
# of Minutes 
Immobile 
The total number of epochs in the given interval scored as immobile 
by the actiware software multiplied by the epoch length in minutes 
Immobile % Time The percentage of epochs in the given interval scored as immobile. 
Scored total immobile time divided by (interval duration minutes total 
invalid time (activity)) multiplied by 100 
# of Minutes Moving The total number of epochs for the given interval scored as mobile by 
the actiware software multiplied by the epoch length in minutes 
Moving % Time The percentage of epochs in the given interval scored as mobile. 
Mobile time divide by (interval duration minus total invalid time 
(activity)) multiplied by 100 
# of Immobile Phases The total number of continuous blocks of epochs where each epoch is 
scored as immobile for the given interval 
Mean Length 
Immobility 
The scored total immobile time divided by the number of immobile 
bouts for the given interval (sleep) 
1 Minute Immobility The number of immobile bouts that are one minute in length for the 
given interval (sleep) 
1 Minute Immobility 
%  
The percentage of immobile bouts that are one minute in length for 
the given interval (sleep) 
Total Activity Score 
 
 
The sum of all valid physical activity counts for all epochs for the 




Table 1 continued 
Mean Activity Score The average of all valid physical activity counts for all epochs for the 
given interval (sleep) 
Fragmentation An index value that includes mobility and short sleep bouts. The sum 
of percent mobile and percent one minute immobile bouts divided by 
the number of immobile bouts for the given interval (sleep) 
Mean Activity/min The average of all valid physical activity counts for all epochs for the 
given interval (sleep) divided by the epoch length in minutes 
Std AC The standard deviation of all valid physical activity counts for all 
epochs for the given interval 
Max AC The largest valid physical activity value recorded during the given 
interval 
Snooze (Sleep Time) The time required to become active after sleep end. The time between 
the end of a given sleep interval and the end of the rest interval, and is 
controlled by the sleep interval detection algorithm 
Note.  
aIndicates Sleep Variable holds translational power to zebrafish larvae.  
bIndicates Sleep Variable holds translational power to zebrafish but is calculated 
differently between species. 






IV. Human Participant Statistical Analysis 
 
All participant information was de-identified and entered into SPSS software 
(SPSS Inc., 2007) for statistical interpretation. Participants were separated into two 
groups denoted “Fat/sugar intake within recommended levels” and “High fat/sugar 
intake”, according to the proposed cut-off score of a total DFS score above 60 likely 
indicating nutrient intake above the World Health Organization’s recommended 
levels[55]. Table 4 shows the group determination of the participants in this study. Sleep 




of the Hayes Lab. Independent sample T-tests were run in order to analyze the 
association between fat/sugar intake and actigraphy output. 
 
 
V. Experimental Model and Animal Subject Details 
 
 For all infection and sleep analysis experiments, AB male and female zebrafish 
larvae (University of Maine, Zebrafish Facility, Orono, ME.) were used with IACUC 





VI. Zebrafish Husbandry 
 
All zebrafish larvae were placed in solution of E3 supplemented with 0.03% of 
1% methylene blue (v/v) from time of collection to 24 hpf (e.g. 50 mL E3 with 16.5 µL 
of methylene blue or 150 mL E3 with 50 µL). Total larvae counts of  ≤ 50 or less were 
kept in 50 mL E3 and total larvae counts of ≤ 150 were kept in 150 mL E3. It should be 
noted that larvae were not treated with N-Phenylthiourea to prevent melanization as the 
natural pigmentation of the larvae was required for the DanioVision device to properly 
track the larvae during the sleep analysis protocols described below. At 24 hpf, larvae 
were transferred to 100% E3 solution of the same volume described above and 
dechorionated with fine tweezers. All petri dishes containing larvae were stored at 28 ºC, 




Plug (GE Lighting Inc.). E3 solution was replaced daily and larvae viability was assessed 
via discoloration (i.e. white, cloudy appearing larvae were presumed dead and removed 




VII. Zebrafish Dietary Preparation 
 
Zebrafish dietary preparation was performed as modified from Arias-Jayo and 
colleagues[72]. For control feed, 1 g of Microgemma 75 (Skretting Zebrafish, 2021.) was 
dissolved in 100 mL deionized water via heated stirring. For high fat feed, 0.9 g of 
Microgemma 75 and 0.1 g of pure Cocoa Butter (Mary Tylor Naturals) was dissolved in 
100 mL deionized water via heated stirring. Both control and high fat feed were 
autoclaved and allowed to cool before feeding periods. Feeding periods occurred once 
per day at 6 pm, or the halfway point of the 10 hour light cycle. Larvae were fed 12.5 mL 
of feed in 150 mL petri dishes for 10 min periods. Control and high fat designated larvae 
were moved to clean petri dishes with fresh E3 following feeding periods. Between 
feeding periods, the control and high fat feeds were stored at 4 ºC in a dim light.  
 
 
VIII. Zebrafish Hindbrain Ventricle Infection 
 
Candida Culture Preparation 
The following steps were conducted in collaboration with Bailey Blair. Zebrafish 




al, Immunology and Infection, 2012). When the to-be-infected larvae were at 1 dpf, an 
overnight culture of Candida albicans SN250 (Homann et al, 2009) in 5 mL 2% YBD 
media was prepared from a pre-prepared streak on LB agar plates. 
 
Injection Preparation and Hindbrain Infection  
 
The following steps were conducted in collaboration with Bailey Blair. The 
morning prior to larvae hindbrain injection (2 dpf), 500 µL of overnight culture was 
placed into a 1.5 mL microcentrifuge tube and centrifuged at max speed for 30 sec. The 
supernatant was discarded and the pellet was resuspended in 500 µL of PBS. The 
remaining solution was then treated with 37.5 µL of Calcofluor white stain (Sigma-
Aldrich, #18909) and incubated at RT for 5 min. The now stained cells were then washed 
three times by addition of 450 µL PBS and centrifugation at max speed for 1 min with the 
supernatant discarded between steps. The stained and washed culture was then serially 
diluted by pipetting 50 µL into 450 µL of PBS to a final dilution of 1 x 10-2 cells/mL. 
Next, 10 µL of the final dilution was counted via hemocytometer and diluted with PBS to 
a final volume of 1 x 107 cells/mL. A micropapillary injection needle was equipped with 
a micropipette puller device. The needle was broken using fine tweezers to create a 
shorter needle tip more optimized for hindbrain infection and to optimize the drop size of 
the needle (i.e. a drop of 1 hemocytometer 1 mm x 1 mm square was preferred).  The 
micropapillary injection needle described above was loaded with Candida injection 
culture, or PBS for control larvae, before being mounted onto a micromanipulator. At 24 




mg/mL)  ~10 min before hindbrain injections were completed. Anesthetized embryos 
were then moved to a Petri dish with a thin layer of 1% agarose to prevent embryos from 
sliding around during infection. A hair loop tool was used to orient the embryos in an 
appropriate location for hindbrain injection (i.e. dorsal side facing towards the needle 
tip). The needle tip was inserted into the hindbrain ventricle from this position and 
injection was confirmed to be in the proper location if a rise in the general anterior 
hindbrain area was observed.  
 
Infected Zebrafish Screening 
 
 The following steps were conducted in collaboration with Bailey Blair. Candida 
infected embryos were placed in 96-well plate (wells B2-G11) in E3 and analyzed via 
Vivotome microscope at 10X magnification, with TL and RL Illumination On, Reflector 
34 BFP, and standard Light path settings. After focusing on each fish, the fine zoom knob 
was used to scan through different cuts of each embryo. Embryos with 10-25 fungal cells 
(i.e. illuminated blue spheres) were kept for sleep analysis and qPCR, embryos above or 





IX. Zebrafish Sleep Analysis 
 
DanioVision sleep analyses were performed as modified from Sorribes and 




larvae was placed into a single well of a 12-well plate in 3 mL of E3 solution. The 
covered 12-well plate was then loaded into the DanioVision device to perform sleep 
analyses (Noldus Inc., . Larvae within the 12-well plate were transported within a 
styrofoam box to minimize light exposure during the tail end of the dark cycle. Each 
larva was then subjected to a 30 min sleep analysis within the DanioVision with a 5 min 
acclimation period. The DanioVision device was pre-programmed to the following 
conditions: Number of tracking sources: 1; Center-point detection (Activity analysis); 
Arenas: 12. Unit of distance: cm; Unit of time: s: Unit of rotation: deg. All data collected 
was directly downloaded within the EthoVision XT program (Noldus, EthoVision XT, ) 
and exported to Excel for further analysis as described below. Single larvae were either 










 Directly following sleep analysis, the 3 mL of E3 within each larvae-containing 
well of the 12-well plate was replaced with a euthanization solution (i,e.10 mL E3, 20 µL 
Tris buffer (pH 9.0), 10 µL lethal Tricaine (400 g/L)) and allowed to sit at RT for 15 min. 
Each euthanized larva was then individually placed in a 1.5 mL microcentrifuge tube, any 
excess euthanization solution was removed and replaced with 200 µL of TRIzol reagent. 




bursts. Homogenized larvae were stored at -80 ºC for later use or the protocol was 
continued as described below. If necessary, samples were thawed on ice within the hood 
prior to adding 800 µL of TRIzol (total 1 mL TRIzol) then centrifuged at 12,000 x g for 
15 min. The supernatant was then transferred to a screw-tap tube. Within the screw-cap 
tube, an additional 1 mL of 95 % ethanol was added and vortexed. This solution was then 
transferred from the screw-cap tube to a Zymo-Spin IIC Column in a collection tube prior 
to being centrifuged at 12,000 x g for 1 min. Next, the solution collected within the 
collection tube (flow-through) was discarded and 400 µL of RNA Wash Buffer was 
added to the same spin column before being centrifuged at 12,000 x g for 1 min. The 
flow-through was once again discarded and 80 µL of DNAse I cocktail (i.e. 5 µL DNAse 
I, 8 µL 10X DNase I Reaction buffer, and 67 µL of DNase/RNase-Free water) was added 
to the same spin column which was incubated at RT for 15 min before being centrifuged 
at 12,000 x g for 30 sec. Without discarding the flow-through, 400 µL Direct-zol RNA 
PreWash was added to the same spin column before being centrifuged at 12,000 x g for 1 
min. The flow-through was discarded before adding 700 µL of RNA Wash Buffer to the 
same spin column which was then centrifuged at 12,000 x g for 1 min. The previous step 
was repeated twice (i.e. three treatments of RNA Wash Buffer in total) before the spin-
column was transferred to the final RNase-free tube. Finally, 50 µL of DNase/RNase-free 
water was added to the column matrix before being centrifuged at max speed for 1 min. 
The spin column was discarded and the eluted RNA was quantified then either stored at -
80 ºC or used immediately for cDNA preparation. RNA stocks were quantified via a pre-
programmed ND1000 Nanodrop Nucleic Acid Program. The nanodrop device was 




RNA stock. RNA stocks with 260/280 values of ~1.8-2, 260/230 values of ~2-2.2, and 




 Following RNA quantification, stored samples were either thawed on ice or 
directly added to a reaction recipe (i.e. 4 µL of 5X reaction buffer, 500 ng RNA stock, 
made up to a total volume of 20 µL using nuclease free water). The volume of RNA 
stock necessary to make 500 ng was determined by dividing 500 ng by the RNA 
concentration determined in the previous section. The volume of nuclease free water 
necessary for the recipe was determined by subtracting the volume of RNA stock being 
added from 15 mL. The complete reaction recipe was moved to thermocycler tubes 
before being treated by a standard thermocycler program. Directly after the thermocycler 
program was completed, 40 µL of nuclease-free water was added into each reaction 





 BioRad SSOSyber Green Supermix (BioRad, #170-8880).was used to perform all 
qPCR analysis. Following cDNA preparation, stored samples were either thawed on ice 
or added directly to the qPCR reaction recipe (i.e. 5 µL of Sybr Green, 0.15 µL of 




diluted cDNA). For large sample sizes, a master mix of Sybr Green, forward primer, 
reverse primer, and nuclease free water was added to each qPCR plate via a multi-
channel pipettor before adding each diluted cDNA sample individually to each well. Each 
cDNA sample was assessed in duplicate with a no-DNA template included for each gene 
being assessed. Each qPCR plate was covered with a clear plastic seal before being 
centrifuged at 5,000 rpm for ~2 sec. The qPCR plate was then treated by the pre-






XI. Zebrafish Sleep Coding 
 
 Downloaded EthoVision XT data exported to Excel was first parsed to only 
include Time (s) and Velocity (cm/s) before being further reduced into 1 s bins (standard 
EthoVision XT outputs are in 1/30th sec bins). The threshold value for immobility of 0.5 
cm/s was then implemented by the equation =IF(B:B>0.5,1,0), where column B indicates 
the velocity column, such that any 1-sec velocity output greater than 0.5 cm/s was coded 
as a 1, or mobile, and any 1-sec velocity output less than 0.5 cm/s was coded as a 0. After 
six consecutive 0s in the binary code, the seventh 0 and any after were coded as sleep. 
Any 1 that interrupted a string of 0s, or sleep bout, was then coded as the start of a wake 
bout. The total sleep duration was determined using the equation =COUNTIF(D:D, “S”), 
where column D indicates the sleep coding column of  “S” or “W” for sleep versus wake 
states. The number of sleep bouts was determined by counting the number of strings of 




highlighted in green and all sleep bouts were filtered and highlighted in purple. To 
calculate the mean sleep bout length, the total sleep duration was divided by the number 
of sleep bouts. To calculate the fragmentation index, the number of sleep bouts was 
divided by the total sleep duration. The Sleep % was determined by dividing the total 
sleep duration by the sum of the total wake duration and total sleep duration. Total wake 
duration was determined using the equation =COUNTIF(D:D,”W”). The number of wake 
bouts was determined by counting the number of strings of “W” in column D. The mean 
wake bout length was calculated by dividing the total wake duration by the number of 
wake bouts. The Wake % was calculated by dividing the total wake duration by the sum 
of the total wake duration and total sleep duration. All sleep variables were converted to 

















Figure 2. Schematic of the experimental workflow for zebrafish larvae reverse 
translational analysis. (A1) Infected group larvae were injected with C. albicans SN250 
culture or mock PBS solution at 1 dpf. (A2) Dietary group larvae were fed high-fat diet 
or typical commercial flake food starting at 3 dpf. (B) All zebrafish larvae were subjected 
to 35 min sleep analysis intervals at 5 dpf. (C) All zebrafish larvae were euthanized, 













Table 2. Translational experimental components for human participants and 
zebrafish larvae. 
 
 Dietary Analysis Sleep Analysis Inflammasome 
Analysis 
Humans Dietary intake was not 
controlled in human 
participants. Experimental 
groups (i.e. Fat and sugar 
intake within recommended 
levels, Fat and sugar intake 
above recommended levels) 
were determined using the 
Dietary Fat and Free Sugar - 
Short Questionnaire. 
All human participants 
were administered a 7 day 
home sleep study. All 
participants slept on the 
UMaine lab teams sleep 
recording system for 2 
nights. All participants 
also wore an actigraphy 
watch for 7 days to serve 
as a positive control for 










Zebrafish  Zebrafish larvae dietary 
intake was controlled. 
Zebrafish were placed into 
control groups and high fat 
groups starting at 3 dpf. 
Control groups were fed 
typical commercial flake 
food. High fat groups were 
fed typical commercial flake 
food supplemented with 
100% cocoa butter. 
All zebrafish larvae were 
subjected to a 35 minute 
interval sleep analysis 
utilizing a Noldus 
DanioVision device at 5 
dpf. 










larvae was used 














XII. Zebrafish Statistical Analysis 
 
 For statistical analysis, calculations were conducted in Excel (Microsoft 
Corporation, 2018), R (R Foundation for Statistical Computing, Vienna, Austria, 2017), 
or GraphPad Prism (La Jolla, CA, USA, 2020) using Shapiro-Wilke test to confirm 
normality and Student’s t-test to assess for variation between experimental and control 
groups. For qPCR analysis, the ΔΔCt value of each group (e.g. control vs. infected, 
healthy diet vs. high fat diet) was compared using Mann-Whitney test. All plots represent 







I. At-Home Sleep Study Demographics 
 
Table 3. Demographics of nutrient intake within recommended levels and high 
fat/sugar intake groups 
Variable 









(n = 5) 
p-value 
Age, y 71.31±0.91 74.28±0.95 n.s. 
Female 77.78%  100.00%         n.s. 
Years of education 15.60±0.35 15.34±0.45 0.069 
Montreal Cognitive Assessment 
(MoCA) 
26.73±0.30 21.54±0.45 n.s. 
Lifestyle factors    
Drinking alcohol 62.2%  56.3%  n.s. 
Current or former smoker 46.7%  54.2%  0.071 
Current use of sleep 
medicationa 
42.2%  41.7%  n.s. 
Body mass index (BMI) 27.60±0.86 28.03±0.92 n.s. 
Obstructive sleep apnea (OSA)  17.8%  28.0%  n.s. 
Diabetes  11.1% 20.8%  n.s. 
Heart attack or cardiac arrest  11.1% 14.6%  n.s. 
Cardiovascular disease  13.3% 18.8%  n.s. 
Cerebrovascular disease  6.7% 16.7% n.s. 
Traumatic brain injury (TBI)  15.6%  18.8% n.s. 
Hypercholesterolemia  42.2%  41.7%  n.s. 
Hypertension  34.1%  47.9%  n.s. 
Arthritis 47.7%  55.4%  n.s. 
Thyroid disease  33.3 %  25.0%  n.s. 
Current depressed mooda  13.3%  37.5%  n.s. 
Note: Values are shown as % or mean ± SE, and compared by independent samples t-test 
(continuous variables) or chi-square test of association (categorical variables). 
a Current use of sleep medication was described as any self-reported use of over the 
counter or prescribed sleep medication over the last month 
b Current depression was indicated by self-report answering the question “Are you 





 In regards to the participant's initial demographic screening, a trend for an 
association between years of education and fat/sugar intake within recommended levels 
was observed. Furthermore, a trend for being a current or former smoker and high 
fat/sugar intake was observed. Finally, it should be noted that all of the participants 
enrolled in my pilot study who were placed into the high fat/sugar intake group were 
female. While these demographic characteristics are not directly applicable to the 
hypothesis of my study, they do provide notable insight into the lifestyle choices and 




II. Dietary Fat and Free Sugar - Short Questionnaire Self Reported Values 
 
Table 4. Saturated fat and free sugar intake scores according to the Dietary Fat and 
Free Sugar - Short Questionnaire 
 




















Sleep fragmentation is both a risk factor for and a symptom of Mild Cognitive 
Impairment, the clinical prodrome of Alzheimer’s Disease. As such, the development of 
early identification diagnostic tools for sleep fragmentation and other disrupted sleep 
patterns could help in preventing the progression of MCI into AD, an agenda which is of 
particular importance for Maine’s aging population. Starting in 2015, the Hayes Lab 
conducted a study which optimized a sensor-embedded mattress device capable of 
diagnosing MCI through one’s sleep quality within a participant’s home environment. 
The objective of this device was to provide a more accessible and affordable option for 
aging individuals to assess their sleep quality, especially for those who had family history 
of sleep disorders and age-related neurodegenerative disorders, in order to mitigate one’s 
risk of developing MCI, AD, and related forms of dementia. As is the case with many 
lifestyle factors, sleep can be impacted by countless factors including dietary choices. For 
this reason, the nutritional profile of each participant enrolled in the at-home sleep study 
was assessed by administering the Dietary Fat and Free Sugar - Short Questionnaire 
(DFS) in order to analyze the power of diet as a moderator of sleep quality and related 
neuropathology. The DFS is a 26 question self-reported survey in which individuals are 
asked to self-rank the frequency of how often they consume certain foods, particularly 
those high in fat and sugar content. Each question is scored 1-5 and the overall survey is 
summated. Those who score ≥60 or greater on the DFS are likely consuming a diet of fat 
and sugar above the WHO’s recommended levels.  
Within the context of the ongoing clinical study, each participant was 
administered the DFS on Day 1, prior to any sleep analysis. The results of the total 




thirteen participants (38.46%) scored equal to or greater than 60 on the DFS, indicating 
that their fat and free sugar intake was above the WHO’s recommended levels. These five 
participants were placed into the ‘High fat/sugar intake’ group while the remaining eight 
participants were placed into the ‘Fat/sugar intake within recommended levels group’. At 
the end of the one week study, these two groups were assessed as potential moderators of 
each sleep variable recorded by the novel sleep recording device. As indicated in Table 3 
below,  Independent sample T-tests were run in order to analyze the association between 
fat/sugar intake and actigraphy output. The sleep metrics described in this pilot study 
were interpreted by actigraph, an accompanying measure to the novel sleep recording 
device (1014). Sleep time was different between groups and strongly increased in the diet 
risk group. Group findings show that “Fat/sugar intake within recommended levels” 
(M=5.78, SD=2.45) and “High fat/sugar intake” (M=14.79, SD=4.62) conditions were 
statistically different, t(11)=-4.66, p = 0.001, revealing greater sleep duration in the High 
fat/sugar intake group. There was a trend for the association in the scores for immobility 
during sleep measured by the mean number of immobile phases between the “Fat/sugar 
intake within recommended levels”group (M=37.13, SD=8.06) and “High fat/sugar 
intake”group (M=52.44, SD=20.41) conditions; t(11=-2.01, p = 0.070). As shown in 
Table 4, actigraphy findings suggest that poor diet increased sleep duration, a companion 
marker of sleep loss, and disrupted motor activity during sleep, measured by more 
transitions from mobile to immobile activity levels, which is consistent with increased 







III. Human Participant Sleep Variables 
 
Table 5. Actigraphy variables for fat/sugar intake within recommended levels and 
high fat/sugar intake groups 
 








Mean Time in Bed 519.67±28.70 524.72± 47.50 n.s. 
Mean Assumed Sleep 499.77±26.81 489.86±45.91  n.s. 
Mean Actual Sleep 
Time 
443.79±30.16  420.21±42.88  n.s. 
Mean Actual Sleep % 88.59±1.92  85.90±3.77  n.s. 
Mean Actual Wake 
Time 
55.76±7.37  69.54±18.46  n.s. 
Mean Actual Wake 
% 
11.41±1.92  14.12±3.77  n.s. 
Mean Sleep 
Efficiency 
85.17±1.77  79.85± 2.72 n.s. 
Mean Sleep Latency 14.12±4.19 20.07±4.79  n.s. 
Mean Sleep Bouts 21.71±2.24  26.97±4.83  n.s. 
Mean Wake Bouts 21.15±2.20  26.50±4.90 n.s. 
Mean Mean Sleep 
Bout Time 
23.84±3.27  17.84±3.12  n.s. 
Mean Mean Wake 
Bout Time 
2.68±0.36 2.68±0.65  n.s. 
Mean Number of 
Minutes Immobile 
428.41±27.69 384.25±41.77  n.s. 
Mean Immobile % 
Time 
85.68±1.89 78.76±5.73  n.s. 
Mean Number of 
Minutes Moving 
71.29±7.92 105.57±27.84   n.s. 
Mean Moving % 
Time 
14.32±1.89 21.19±5.76  n.s. 
Mean Number of 
Immobile Phases 
37.13±2.69 52.44±10.21  0.070 
 
 




Table 5 continued 
Mean Mean Length 
Immobility 
12.47±1.07  9.16±2.47  n.s. 
Mean One Minute 
Immobility 
7.44±1.25 13.29±3.96  n.s. 
Mean One Minute 
Immobility % 
18.16±1.84 22.62±5.69  n.s. 
Mean Total Activity 
Score 
8282.05±1418.17  9445.93±2764.52  n.s. 
Mean Fragmentation 
Index 
32.48±3.74  43.85±11.40  n.s. 
Sleep Time 5.78±0.82  14.79±2.31  0.001 
Note. x ± y represents the mean  ± standard error of the mean (SEM), (n) = sample size.  
Note. x ± y represents the mean  ± standard error of the mean (SEM), (n) = sample size.  
 
 
The results reported of the at-home sleep study stimulated the idea for a reverse-
translational follow-up study which aimed to further elucidate the putative molecular and 
physiological mechanism connecting Western Diet to perturbed sleep quality. It was 
hypothesized that Western Diet, a known inducer of gut dysbiosis and systemic 
inflammation, triggered pro-inflammatory signaling pathways involving pyrogenic and 
somnogenic cytokines which caused the observable sleep disruption. In order to assess 
the above hypothesis, zebrafish were selected as a model organism given that they have 
comparable sleep ontogeny to humans as well as a highly homologous immune system. It 
was hypothesized that zebrafish who were experiencing systemic inflammation would 
produce greater immune gene expression of inflammatory cytokines with both pyrogenic 
and somnogenic effects. In addition to this, it was hypothesized that such differential 
cytokine gene expression would serve as a moderator for perturbed sleep quality in 
zebrafish larvae. Inflammation was induced in zebrafish larvae by direct infection with 




positive control, or by a high fat diet, meant to serve as an experimental model for the 
Western Diet consumed by human participants in the initial sleep study. Respective 
controls for each method of inflammation were also incorporated (i.e. half of the infected 
group was injected with a mock-PBS solution and half of the dietary group was fed 
normal commercial flake food). Following inflammation induction, as elicited via 
pathogen infection or a high fat diet, each zebrafish larva was subjected to a 35 minute 
sleep analysis within the last hour of their 14 hour dark cycle and subsequently 
euthanized for single fish qPCR analysis. This overall experimental workflow was 
repeated such that the 6 replicate sleep analysis trials and 2 replicate qPCR analyses were 
conducted for the infected group and 4 replicate sleep trials and 2 replicate qPCR 
analyses were conducted for the dietary group. However, only 1 of the sleep trials 
performed for the dietary group was used for data analysis due to experimental error 
involving file export within the Noldus EthoVision XT program. The results of both the 














Figure 3. Total sleep and wake duration (minutes) and sleep and wake % for Mock 
PBS Injected and Active Candida Infection zebrafish larvae in repeat sleep analysis 
Trials 1-6. (A) Total Sleep Duration of control and infected zebrafish.  (B) Total wake 
duration of control and infected zebrafish larvae. Though not shown here, sleep and wake 
% depicted identical results to total sleep and wake duration. Bar plots and error bars 
represent Mean and SD. *p<0.05. **p<0.01. ***p<0.001. ****p<0.0001. 
 
 All sleep variables analyzed in zebrafish larvae were selected on previous 
optimization and proof-of-concept analyses as well as reverse-translational power to 
human actigraphy variables. Zebrafish larvae sleep analyses were conducted at 35 min 
intervals within the last hour of the assigned 14-hour dark cycle. Zebrafish sleep analysis 
is distinct from humans in that measures pertaining to time spent ‘in bed’ (e.g. Sleep 
Latency) cannot accurately be assessed. However, total sleep and wake duration and 




sleep and wake bouts, and fragmentation indexes (Figure 4) are mutual sleep variables 
which have been reported in both humans and zebrafish. Thus, in the place of actigraphy 
sensors, zebrafish immobility and velocity states can be used to predict sleep and 
wakefulness as well as the transition between these two states. As observed in Figure 3 
above, sleep variables are highly irregular between identical repeat experiments as well 
as within some experimental groups. This observation could serve to explain the absence 
of a statistically significant difference between each sleep variable in the Active Candida 
Infection group (n=56) and the Mock PBS Injection group (n=55) data sets (Appendix 
C). However, statistically significant observations can still be used to assess trending 
results between experiments. 
For all zebrafish sleep variables, sample normality was assessed by Shapiro-Wilk 
test and independent variables were assessed by Student’s t-test. In 80% of infected 
zebrafish sleep analyses, the Active Candida Infection group exhibited a greater total 
sleep duration and sleep %, and subsequently a lower Total Wake Duration and Wake %, 
than the Mock PBS Injection group. Moreover, Trials 1, 2, and 5 exhibited statistically 
significant variation in these sleep parameters (Trial 1: n=20, p=0.01831.Trial 2: n=22, 




Figure 4. Number of sleep and wake bouts, mean sleep and wake bout length 
(minutes), and fragmentation indexes for PBS injected and active Candida infection 
zebrafish larvae in repeat sleep analysis Trials 1-6. (A) Total Sleep Duration of control 




(C) Sleep % of control and infected zebrafish larvae. (D) Wake % of control and 
zebrafish larvae. Bar plots and error bars represent Mean and SD. *p<0.05. **p<0.01. 
***p<0.001. ****p<0.0001. 
 
 In 60% of infected zebrafish sleep analyses the Active Candida Infection group 
exhibited a greater number of sleep bouts than the Mock PBS Injection though only Trial 
5 yielded statistically significant results (Trial 5: n=22, p=0.00135). Similarly, in 80% of 
infected zebrafish sleep analysis the Active Candida Infection group exhibited a greater 
mean sleep bout length than the Mock PBS Injection group though only the results of 
Trial 1 were statistically significant (Trial 1: n=20, p=0.005955). Regardless of sleep bout 
length, by definition the end of each sleep bout must simultaneously signal the beginning 
of a wake bout. Thus, larvae who had a higher Number of Sleep Bouts also yielded a 
higher number of wakebBouts. While this may not appear to add obvious information for 
analysis, wake variables are an integral part of human sleep analysis and, thus, should be 
included for zebrafish sleep studies to maintain reverse translational power. Such 
characteristic brief, intermittent arousals in zebrafish larval sleep was further quantified 
by the fragmentation index. Specifically, in 60% of infected zebrafish sleep analyses the 
Active Candida Infection group exhibited a lower fragmentation index than the Mock 
PBS Injection group with both Trials 1 and 2 yielding statistically significant results 
(Trial 1: n=20, p=0.009936, Trial 2: n=22, p=0.021788). The results reported in Figures 3 
and 4 indicate that zebrafish experiencing inflammation induced via direct pathogen 
infection tend to have more frequent sleep bouts (i.e. periods of immobility), longer sleep 




V. High Fat Diet Zebrafish Sleep Analysis 
 
 
The results of the infected zebrafish sleep analysis are not inconsistent with the 
hypothesis that zebrafish larvae experiencing strong inflammation induced by fungal 
pathogen Candida exhibit perturbed sleep quality, particularly in regards to sleep 
duration and the number and length of sleep bouts (Figures 3, 4). As such, given that the 
infected zebrafish group was meant to serve as a positive control for the putative 
inflammatory pathways hypothesized to be triggered by a high fat diet, further 
experimentation was done to assess the power of a high fat diet as a moderator of sleep 
quality in zebrafish. 
Beginning at 3dpf, following manual dechorionation at 2 dpf and expected 
development of a functioning digestive tract occurring as early as 3 dpf, zebrafish larvae 
were split into ‘Control Diet’ and ‘High Fat Diet’ groups. The Control Diet was prepared 
by suspending 1 g of Gemma 75 commercial flake food (Skretting Zebrafish, 2021.) in 
100 mL of deionized water. The High Fat Diet was prepared under similar conditions but 
was supplemented with 10% (w/w) pure cocoa butter mixed via heated stirring. Both 
feeds were autoclaved and allowed to cool at room temperature prior to feeding in order 
to mitigate the risk of bacterial colonization of the feed prior to consumption as this 
would induce non-high fat diet-mediated gut microflora shift and potentially 
inflammatory signaling. Identical statistical analyses were performed on the high fat 
zebrafish group. As was observed in the infected zebrafish group, diet-controlled 
zebrafish displayed highly variable sleep metrics between identical repeat experiments. 




Figure 5. Total sleep and wake duration (minutes) in control diet and high fat diet 
zebrafish larvae in repeat sleep analysis Trials 1-6. (A) Total Sleep Duration of control 
and high fat fed zebrafish.  (B) Total wake duration of control and high fat fed zebrafish 
larvae. Though not shown, sleep and wake % depict identical results to total sleep and 
wake duration. *p<0.05. **p<0.01. ***p<0.001. ****p<0.0001. 
 
Though no values were found to be statistically significant, the results in Figure 5 
report that High Fat fed zebrafish generally exhibited depressed total sleep duration and 
sleep % and subsequently a greater total wake Duration and Wake %. Though any lack of 
statistical significance could be due to uneven control and experimental groups as well as 
a small sample size. Similarly, as shown in Figure 6 below, high fat fed zebrafish had a 
greater number of sleep bouts and shorter mean sleep bout lengths than control diet fed 
zebrafish. Furthermore, high fat fed zebrafish exhibited a greater fragmentation index 
than control diet fed zebrafish. Future research should repeat this experiment to produce a 
larger sample size in order to account for natural variability in zebrafish larvae sleep 





Figure 6. Number of sleep and wake bouts, mean sleep and wake bout length 




larvae in repeat sleep analysis Trials 1-6. (A) Total sleep duration of control and high 
fat fed zebrafish.  (B) Total wake duration of control and high fat zebrafish larvae. (C) 
Sleep % of control and high fat fed zebrafish larvae. (D) Wake % of control and high fat 
fed zebrafish larvae. Bar plots and error bars represent Mean and SD. *p<0.05. **p<0.01. 
***p<0.001. ****p<0.0001. 
 
 While statistically significantly differential sleep quality was observed in Candida 
infected zebrafish larvae, and non-significant differences were observed in high fat fed 
zebrafish larvae, these associative observations were not sufficient to address the entire 
aim of this study. Namely, single fish qPCR experimentation was necessary to elucidate 
if elevated somnogenic and pyrogenic cytokine expression mediated perturbed sleep 
quality in either group. In order to accomplish this, directly following sleep analysis each 
larvae was euthanized, homogenized, and stored at -80 ºC for future use in quantitative 
real time PCR (qPCR). 
 
 
VI. Infected Zebrafish qPCR Analysis 
 
 As with any qPCR experimental design, it was critical that proper target genes 
were selected for analysis in order to accurately address the hypothesis that pro-
inflammatory cytokines served to induce sleep disruption in both Candida infected and 
high fat fed zebrafish. As such, TNF-ɑ, IL-1β, and IL-6 were assessed in both zebrafish 
experimental groups as, to date, these signaling molecules are the most comprehensively 
understood cytokines known to regulate both the pro-inflammatory response and sleep 




Figure 7. Gene expression of TNF-ɑ (Blue) and IL-6 (Green) is upregulated (n.s.) in 
Candida infected zebrafish larvae. Il-1β (Red) is depressed (n.s.) in Candida infected 
zebrafish larvae. (A) qPCR Trial 1. (B) qPCR repeat Trial 2. (C) Pooled ΔΔCt of Trial 1 
and 2. Bar plots and error bars represent Mean and SD. Ct values correspond to initial 
qPCR Cycle threshold output values. ΔCt values indicate the difference between target 
and non-target gene expression. ΔΔCt values indicate the difference between single 
Candida infected larvae ΔCt values and the average ΔCt value of control larvae. Thus, -
ΔΔCt values represent the direction of fold change in gene expression. 
 
 qPCR Real-Time Systems produce cycle threshold (Ct) values which are 
inversely proportional to the levels of targeted mRNA in the provided sample. Though Ct 
values serve as necessary intermediates in any qPCR analysis, they do not provide 
meaningful quantitative data which can easily be interpreted. As such,  ΔCt,  ΔΔCt, and 




only metric which maintain the identity of a single zebrafish larvae’s gene expression. 
ΔCt values are calculated by subtracting the housekeeping gene (i.e. GAPDH) expression 
of a particular larvae from the target gene expression of a particular larvae. As such, ΔCt 
values serve to show the difference between target and control, baseline samples. Further, 
ΔΔCt serves to explain the difference between a treated and untreated sample. ΔΔCt 
values are calculated by subtracting the average ΔCt of a control larvae from the ΔCt of 
an individual experimental larvae. In this manner, ΔΔCt values indicate differential 
expression induced by the experimental moderator. Given that gene expression fold 
change can be calculated by the negative log base two of ΔΔCt values, a negative ΔΔCt 
value is indicative of elevated gene expression and a positive ΔΔCt is indicative of 
depressed gene expression when comparing the treated group to the control group. Or, as 
seen in Appendix F, infected larvae who exhibit a negative ΔΔCt value for a target 
cytokine produce fold change values above 1 indicative of elevated gene expression 
while infected larvae who exhibit a positive ΔΔCt value produce fold change values 
below 1 indicative of depressed gene expression. In Figure 7 above, it can be seen that in 
both Trial 1, Trial 2, and the pooled data set for infected larvae zebrafish, TNF-ɑ and IL-
6 both have negative ΔΔCt values while IL-1β has a positive ΔΔCt value. Thus, the 
experimental replicate results suggest that direct Candida infection serves to upregulate 












VII. High Fat Diet Zebrafish qPCR Analysis 
 
 As discussed above, the strong positive control for pro-inflammatory and 
somnogenic cytokine release, direct Candida infection, was shown to be correlated with 
perturbed sleep quality and elevated expression of cytokines TNF-ɑ and IL-6. These 
results incited investigation into the hypothesized mechanism of high fat-mediated gut 
dysbiosis-inducing systemic inflammatory pathways. As such, identical experimental 
methods were conducted as was described within the infected zebrafish group except 
ΔΔCt values were calculated in order to identify differential gene fold expression for high 
fat diet treated zebrafish as compared to control diet fed zebrafish. 
Figure 8.  Gene expression of IL-1β (Red) and IL-6 (Green) is upregulated (n.s.) in 
Candida infected zebrafish larvae. TNF-ɑ (Red) is depressed (n.s.) in Candida infected 
zebrafish larvae. Pooled ΔΔCt of high fat diet qPCR replicate experiments Trial 1 and 2 




Mean and SD. Ct values correspond to initial qPCR Cycle threshold output values. ΔCt 
values indicate the difference between target and non-target gene expression. ΔΔCt 
values indicate the difference between single high fat diet treated larvae ΔCt values and 
the average ΔCt value of control larvae. Thus, -ΔΔCt values represent the direction of 
fold change in gene expression. 
 
 As seen in Figure 8 above, both IL-1β and IL-6 exhibit negative ΔΔCt values 
when comparing high fat fed zebrafish larvae gene expression to that of control diet 
zebrafish larvae. However, the differential expression observed in both TNF-ɑ and IL-1β 
shown above is relatively insignificant, or close to zero, while IL-6 appears to be highly 
upregulated in comparison. Most notably, IL-6 also showed the most profound negative 
ΔΔCt value, and therefore the greatest increase in gene fold expression, in the pro-
inflammatory positive control group, Candida infected zebrafish. Thus, qPCR analysis of 
both the infected zebrafish larvae and the high fat diet treated zebrafish larvae could 
provide grounds suggesting that both infection and Western Diet elicit an IL-6 mediated 
pro-inflammatory response leading to perturbed sleep states. At the same time, however, 
future research will need to assess the relatively low sample size in both experimental 
groups in order to compensate for the natural variation of cytokine gene expression 










VIII. Correlation Between Pro-inflammatory Cytokine Gene Expression and Specific 
Zebrafish Sleep Variables 
 
 The differentially expressed pro-inflammatory cytokine gene expression observed 
between control and experimental groups treated with different means of inflammation-
inducing mechanisms holds promise for future work in elucidating the physiological 
phenomena underlying the connection between diet and sleep quality, particularly in 
regards to the role of IL-6 in modulating these events. As such, exploratory correlation 
models were conducted to attempt to pinpoint an association between specific elevated 
cytokine gene expression and distinct sleep variable metrics. The results of these 
exploratory analyses for both Trial 1 and Trial 2 of the Candida infected experimental 
group are described below. The high fat diet experimental group was not incorporated in 
these analyses due to low sample size and absence of single fish sleep metrics in both 














Figure 9. Exploratory linear regression analyses of individual sleep variables and 
TNF-ɑ (Blue), IL-1β (Red), and IL-6 (Green) ΔCt values for infected zebrafish 
qPCR Trial 1. (A) Single fish Total Sleep Duration (minutes). (B) Single fish sleep %. 
(C) Single fish number of sleep bouts. (D) Single fish mean sleep bout length (minutes). 
(E) Single fish fragmentation index. All sleep variables are plotted against the single fish 




 While the ΔΔCt typically provides information necessary for interpreting gene 
fold expression, it eliminates the quantification of zebrafish at the single larvae level 
given that it is calculated by subtracting the average ΔCt of the control group from the 
single fish ΔCt of each experimental larvae. Thus, in order to assess a relationship 
between each individual fish’s inflammatory cytokine expression profile and sleep 
quality, ΔCt values were plotted as opposed to ΔΔCt values. In these plots, each point 
represents a single fish with the y-axis indicating its ΔCt value for a given target gene and 
the x-axis indicating its sleep quality described by the defined variable. As such these 
plots allow for quantification of any potential relationship between pro-inflammatory 
cytokine ΔCt values and sleep disruption of single zebrafish larvae. Least squares 
regression lines were fitted to each cytokine, TNF-ɑ (Blue), IL-1β (Red), and IL-6 
(Green), and the R2 value of each regression line was interpreted to quantify how well 
each regression line fit the dataset. R2 values have a range from 0-1 with 1 being a perfect 
fit to the linear descriptive equation. However, the only R2 value reporting over 50% 
(0.5) was that which described the relationship between elevated IL-1β expression and 
single fish Fragmentation Indexes (R2=0.6723). Thus, the exploratory analyses of the 
infected zebrafish larvae Trial 1, as well as the sleep variables of each single fish being 






Figure 10. Exploratory linear regression analyses of individual sleep variables and 
TNF-ɑ (Blue), IL-1β (Red), and IL-6 (Green) ΔCt values for infected zebrafish 
qPCR Trial 2. (A) Single fish total sleep duration (minutes). (B) Single fish Sleep %. 
(C) Single fish number of sleep bouts. (D) Single fish mean sleep bout length (minutes). 
(E) Single fish fragmentation index. All sleep variables are plotted against the single fish 




 Identical plotting methods were conducted for infected zebrafish larvae qPCR 
Trial 2. As seen in the scatterplots above(Figure 10) and numerically in Appendix H, the 
ΔCt values of qPCR Trial 2 were much tighter than those of Trial 1. Thus, more 
information could be determined from plotting the results of the qPCR experiment 
against the single fish sleep variables discussed previously. Again, linear least squares 
regression lines were calculated with any linear regression reporting an R2 value over 0.5 
being deemed an acceptable ‘fit’. A trend for the correlation was observed between 
inflammatory cytokine ΔCt values and individual sleep variables in infected zebrafish 
larvae. For one, a correlation between increased TNF-ɑ expression (R2=0.8819) as well 
as increased IL-6 expression (R2=0.8212) and an increase in the number of sleep bouts 
was observed. Further, a correlation between increased TNF-ɑ expression (R2=0.9279) 
and elevated mean sleep bout length was observed. Finally, a correlation between 
increased IL-6 expression (R2=0.6567) and greater Fragmentation Indexes was observed. 









 Clinical implications of sleep disturbances are becoming increasingly apparent 
thereby increasing the demand for research aimed at elucidating the physiological 
mechanisms which relate disease states and sleep disruption. Further, a more robust 
understanding of how basic lifestyle factors, such as diet, influence sleep quality is a 
critical component of such research. Preliminary results reported by Hayes suggested that 
aging adults who consumed a diet higher in fat and free sugar exhibited poorer sleep 
quality, particularly in regards to sleep duration-related metrics and sleep fragmentation. 
In line with previous work which has found that Western diet induces gut-dysbiosis as 
well as elevated pro-inflammatory cytokine expression it was subsequently hypothesized 
that aging individuals who consumed a more severe Western diet experienced pro-
inflammatory signaling known to contribute to sleep disruption[80,81]. To assess parts of 
this hypothesized mechanism of causation, a reverse-translational protocol was optimized 
to attempt to model this phenomenon in zebrafish. Zebrafish larvae (≤5 dpf) were 
administered a high fat or control diet beginning at 3 dpf before being subjected to a 35 
minute sleep analysis at 5 dpf. Another experimental group of zebrafish was not 
controlled by diet but instead received direct infection of human fungal pathogen, 
Candida, or a mock infection. Both were intended to mimic the hypothesized 
inflammatory state induced by the aforementioned high fat diet. Following sleep analysis, 
each larvae was used for single fish qPCR to measure pyrogenic cytokine gene 
expression. The pro-inflammatory cytokines selected (i.e. TNF-ɑ, IL-1β, and IL-6) were 
selected as they are also known to have somnogenic properties[23]. Thus, cytokine gene 




disruption was observed and subsequently if any perturbed sleep quality was correlated 




Figure 11. Schematic representation of how each component of the reverse-
translational study aimed to address a unique piece of the multi-part hypothesis. (A) 
The 35 min zebrafish sleep analysis was designed to first identify if Candida infected or 
high fat diet treated zebrafish larvae exhibited sleep disruption when compared to their 
respective controls (Figures 3-6). (B) The post-sleep analysis qPCR method was designed 
to assess if Candida infected or high fat diet treated zebrafish larvae exhibited greater 
pro-inflammatory cytokine gene expression (Figures 7-8). (C) The sleep vs. qPCR 
scatterplots were designed to assess if differential sleep quality observed in either 
Candida infected or high fat diet treated zebrafish larvae was associated with pro-




controlled group, this experimental design was meant to assess each particular piece of 
the multi-part hypothesis that Western diet induced gut-dysbiosis was the trigger for pro-
inflammatory cytokine mediated sleep disruption. 
 
Our preliminary results suggest for the first time that infected zebrafish larvae and 
high fat diet treated zebrafish larvae both exhibit a greater number of sleep bouts than 
their respective controls as well as a possible trend (not statistically significant) for 
elevated IL-6 gene expression. Though future studies are necessary to compensate for the 
small sample size of the dietary group in the present study, these results suggest that a 
pro-inflammatory signaling pathway may be induced by a high fat diet in zebrafish and 





Zebrafish Sleep Analysis 
 
In 80% of replicate sleep analysis trials, Candida infected larvae exhibited greater 
total sleep duration, sleep %, and mean sleep bout length than control larvae and, in 60% 
of replicate sleep analysis trials, Candida infected zebrafish larvae exhibited a greater 
number of sleep bouts than control larvae. Similarly, though no statistically significant 
correlations or trends were noted, high fat diet treated zebrafish larvae exhibited a greater 
number of sleep bouts and fragmentation index than control diet larvae. The high 
variability of sleep quality between control and experimentally-treated zebrafish in repeat 
experimental trials highlights the importance for further optimization of velocity-based 




al (2013) required several non-data producing trials due to pitfalls that were not described 
in previous literature[3]. Namely, the use of 1-phenyl 2-thiourea (PTU) to inhibit the 
pigmentation of zebrafish larvae, a common practice in zebrafish husbandry to simplify 
injection and imaging procedures, disrupted the ability of the Noldus Vision Device from 
differentiating the nearly translucent larvae from the clear background water. Thus, the 
protocol was modified to not include PTU treatment with zebrafish larvae up to 5 dpf. 
Even once pre-sleep analysis husbandry was designed in a manner such that larvae could 
properly be distinguished from background signal of flow-by water, high variability was 
observed between experimental trials. In part, this could be due to the fact that the young 
zebrafish larvae were not fully entrained to the 10-hour light/14-hour dark cycles and, 
thus, their circadian rhythm and behavioral sleep state may have been at different points 
during the designated sleep analysis period.  However, given that previous research 
reports that zebrafish sleep-wake transitions decrease with age, larvae were determined to 
be the most appropriate model in assessing fragmentation-related variables, were more 
conducive to a time-restricted study, and offer a variety of physiological advantages to 
older zebrafish larvae (e.g. natural translucent appearance simplifies infection protocols). 
Future studies could also assess zebrafish sleep analysis at different time points during 
the day (e.g. ‘morning’ for early in light cycle, ‘afternoon’ for midway point of light 
cycle, etc.) to monitor light-dark entrainment or even, with more optimization, to assess 
‘daytime sleepiness’. While large variability may have rendered the pooled zebrafish 
sleep variables (Appendix C) non-statistically significant, assessing trends within 
biological repeat trials appeared to produce several noteworthy trends. Namely, that 




number of sleep bouts, and mean sleep bout length when compared to non-infected larvae 
administered a placebo mock injection. This suggests that Candida infection induces 
sleep disruption in zebrafish larvae. Furthermore, though not observed to be statistically 
significant, high fat fed zebrafish larvae also exhibited a greater number of sleep Bouts as 
well as a larger fragmentation index. This suggests that a high fat diet is associated with a 
trend for sleep disruption in zebrafish larvae. The uneven control and experimental group 
size and lack of biological replicates likely contributed to the lack of statistically 
significant findings of the diet-controlled zebrafish group. In summary, despite a lack of 
statistical evidence for the high fat treated zebrafish group, these findings are not 
inconsistent with the hypothesis that a high fat diet or direct infection would induce sleep 
disruption in zebrafish larvae. In order to elucidate if these associative findings were 
mediated by pro-inflammatory cytokine signaling, the gene expression of TNF-ɑ, IL-1β, 






Zebrafish Inflammatory Cytokine qPCR Analysis 
 
 To investigate the our hypothesis that inflammatory signaling would disrupt sleep 
in zebrafish larvae, each zebrafish larvae measured for sleep analysis was subjected to 
single fish qPCR aimed at quantifying gene expression of the extensively studied 
pyrogenic and somnogenic cytokines TNF-ɑ, IL-1β, and IL-6. The initial qPCR Trial 1 of 
the infected zebrafish group showed wide variability between biological replicates and 




experimental technique as subsequent repeat trials for both infected and diet-controlled 
were considerably more consistent and properly controlled (Appendix F, G). Using a 
Mann-Whitney test to compare the ΔΔCt of Candida infected and control zebrafish 
larvae, no statistically significant associations nor trends were reported. The depressed -
ΔΔCt of IL-1β in Trials 1 and 2 of the infected larvae contradicted the anticipated result 
that IL-1β would be upregulated in the presence of fungal infection (Fradin et al 2007). 
This result, however, could be due to natural variability between zebrafish larvae and not 
necessarily an actual downregulation of IL-1β in infected zebrafish. What was observed 
in both Trials 1 and 2, as well as the pooled data set, was a non-significant increase in 
TNF-ɑ and particularly IL-6 expression as gathered by the -ΔΔCt values(Figure 7). This 
suggests that infected zebrafish larvae are associated with both sleep disruption and a 
trend for elevated gene expression of inflammatory cytokines TNF-ɑ and IL-6.  
In regards to the diet-controlled zebrafish group, given the small sample size and 
absence of statistically significant variation between control and experimental groups, the 
minimal change in both TNF-ɑ and IL-1β gene expression did not come as a surprise. 
However, similar to that of the infected zebrafish group, there was an increase in IL-6 -
ΔΔCt as compared to control zebrafish larvae. In future studies, this experiment should 
attempt to be replicated to further support this preliminary observation. However, the 
consistent elevated gene expression of IL-6 in both Candida infected and high fat diet 
treated zebrafish larvae may support a mutual inflammatory pathway inducted by two 
distinct external factors.  
 Several statistically significant associations were noted, consistent with the 




non significant trend for an association correlating Candida infection and high fat diet 
treatment to elevated IL-6 gene expression was observed. However, these findings were 
not consistent between entire control or treated groups due to wide variability between 
both sleep variables and gene expression in repeat experimental trials. However, to 
determine if any relationship between elevated inflammatory cytokine gene expression 
and sleep disruption could be observed at the single fish level, each single fish ΔCt value 
was plotted against each single fish sleep variable (Figure 9 and 10). As indicated by 
more statistically relevant least squares linear regression R2 values being observed in 
infected qPCR Trial 2, identifying any correlation between inflammatory cytokine gene 
expression and sleep variables requires tight qPCR biological replicate production. While 
several interesting trends were observed which suggested an association between pro-
inflammatory cytokine elevated gene expression and differential sleep quality, the 
relatively small sample size of each single fish qPCR (ranging from 2-5 larvae) may have 
skewed these results. In addition to this, like humans, each zebrafish larvae is not 100% 
genetically identical so variation in sleep quality, response to diet, or response to 




















 Future work should aim both to further optimize the methods of this study as well 
as to attempt to elucidate more of the molecular interactions which may underlie the 
correlations observed between inflammatory cytokine gene expression and sleep 
disruption. In regards to experimental method improvements, this study should be 
replicated with non-velocity based zebrafish sleep analyses so that sleep variables 
involved in immobility, which are commonplace metrics in human sleep analysis, can be 
analyzed as well. That is, while metrics such as mean number of immobile phases may be 
assessed in humans, given that sleep was defined in zebrafish as periods of immobility, it 
is impossible to distinguish general sleep-like behavior from immobile phases within 
sleep. In addition to this, a checkpoint step between high fat feeding and inflammatory 
cytokine gene expression could be done, such as 16s rRNA analysis (e.g.Arias-Jayo, 
2018) in order to confirm diet-induced gut dysbiosis prior to assessing differential 
inflammatory signaling. Furthermore, assessing the results of identical experimental 
methods on zebrafish at different stages during development, namely adult zebrafish, 
could prove interesting given that longer exposure to a high fat diet could have a greater 
impact on the state of typical gut microflora and subsequent immune response.  
 In regards to further research involving the molecular mechanisms underlying the 
relationship between diet and sleep quality in zebrafish, the most promising result of the 
provided study was the mutual elevation of IL-6 gene expression observed in both high 
fat diet treated zebrafish, who were hypothesized to be experiencing gut-dysbiosis 
induced inflammation, as well as Candida infected zebrafish, who were meant to serve as 




foremost attempt to replicate these findings in larger sample sizes and then attempt to 
elucidate if elevated IL-6 production is specific to any tissue(s) in infected and high fat 
diet treated zebrafish. Future work could even attempt to create mutant fluorescently 
tagged IL-6 zebrafish optimized such that, when activated, the upstream IL-6 promoter 
would induce gene expression of a fluorescent IL-6 protein, such that the location and 
fluorescence quantification of IL-6 expression in infected and diet-controlled zebrafish 
could be assessed via microscopy techniques. Namely, it would be interesting to observe 
if IL-6 expression, which would first elevate at the site of infection (i.e. hindbrain) or 
within the gut, could be observed to travel throughout the CNS in the case of hindbrain 
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Zebrafish Sleep Variables for Infected Sleep Analysis Trials 1-6 
 
 
Sleep Variables for Mock PBS Injection vs. Active Candida Infection Trial 1 Groups 
 





Total Sleep Duration 30.72 ± 1.62 31.79 ± 3.73 0.01831 
Number of Sleep 
Bouts 
29.27 ± 10.67 15.22 ± 8.27 0.002322 
Mean Sleep Bout 
Length 
1.19 ± 0.49 2.97 ± 2.05 0.005955 
Fragmentation Index 0.972 ± 0.419 0.519 ± 0.362 0.009936 
Sleep % 87.86 ± 4.57 90.84 ± 10.66 0.01831 
Total Wake Duration 4.282  ± 1.625 3.207 ± 1.358  0.01831 
Number of Wake 
Bouts 
30  ± 10.67 16.22 ± 7.432 0.002322 
Mean Wake Bout 
Length 
0.14  ± 0.03 0.164 ± 0.026 0.44038 
Wake % 12.14  ± 4.57 9.159 ± 3.876 0.01831 






Sleep Variables for Mock PBS Injection vs. Active Candida Infection Trial 2 Groups 
 





Total Sleep Duration 13.10 ± 5.08 17.77 ± 3.61 0.012241 
Number of Sleep 
Bouts 
77.00 ± 10.63 82.00 ± 16.17 0.197143 
Mean Sleep Bout 
Length 
0.17 ± 0.08  0.22 ± 0.06 0.070101 
Fragmentation Index 6.85 ± 2.77 4.774 ± 1.367 0.021788 
Sleep % 37.44 ± 14.51 50.76 ± 10.31 0.047857 
Total Wake Duration 21.90 ± 5.08 17.235 ± 2.289 0.012241 
Number of Wake 
Bouts 
78 ± 10.63 83 ± 16.17 0.197143 
Mean Wake Bout 
Length 
0.284 ± 0.071 0.192 ± 0.101 0.00466 
Wake % 43.43 ± 14.51 52.02 ± 13.54 0.047857 








Sleep Variables for Mock PBS Injection vs. Active Candida Infection Trial 3 Groups 
 





Total Sleep Duration N/A 25.58 ± 5.23 N/A 
Number of Sleep 
Bouts 
N/A 49.40 ± 16.74 N/A 
Mean Sleep Bout 
Length 
N/A 0.58 ± 0.27 N/A 
Fragmentation Index N/A 2.048 ± 0.089 N/A 
Sleep % N/A 73.08 ± 14.95 N/A 
Total Wake Duration N/A 9.42 ± 5.23 N/A 
Number of Wake 
Bouts 
N/A 50 ± 16.74 N/A 
Mean Wake Bout 
Length 
N/A 0.188 ± 0.104 N/A 
Wake % N/A 26.918 ± 14.95 N/A 






Sleep Variables for Mock PBS Injection vs. Active Candida Infection Trial 4 Groups 
 





Total Sleep Duration 19.75 ± 3.34 22.43 ± 6.24 0.116424 
Number of Sleep 
Bouts 
70.82 ± 10.68 67.33 ± 28.50 0.35553 
Mean Sleep Bout 
Length 
0.28 ± 0.06 0.58 ± 0.72 0.46812 
Fragmentation Index 3.592 ± 0.747 3.498 ± 2.032 0.443771 
Sleep % 56.42 ± 9.53 66.65 ± 18.94 0.111016 
Total Wake Duration 15.256 ± 3.35 12.566 ± 6.242 0.116424 
Number of Wake 
Bouts 
71.818 ± 10.675 68.33 ± 28.504 0.35553 
Mean Wake Bout 
Length 
0.219 ± 0.074 0.175 ± 0.029 0.07493 
Wake % 43.58 ± 9.53 35.35 ± 18.94 0.111016 










Sleep Variables for Mock PBS Injection vs. Active Candida Infection Trial 5 Groups 
 





Total Sleep Duration 26.26 ± 3.19 16.12 ± 6.84  0.000173 
Number of Sleep 
Bouts 
51.00 ± 17.55 76.92 ± 24.68  0.00135 
Mean Sleep Bout 
Length 
0.64 ± 0.44 0.51 ± 1.15 0.00056 
Fragmentation Index 2.023 ± 0.860 5.972 ± 3.042 0.000385 
Sleep % 75.53 ± 9.10 46.07 ± 19.53 0.000145 
Total Wake Duration 8.738 ± 3.187 18 ± 6.843 0.000173 
Number of Wake 
Bouts 
52 ± 17.55 77.917 ±24.678 0.00135 
Mean Wake Bout 
Length 
0.168 ± 0.023 0.240 ± 0.044 0.00027 
Wake % 24.575 ± 9.097 53.928 ± 19.525 0.000145 








Sleep Variables for Mock PBS Injection vs. Active Candida Infection Trial 6 Groups 
 





Total Sleep Duration 15.804 ± 6.886 15.904 ± 6.913 0.42074 
Number of Sleep 
Bouts 
74.833 ± 22.894 76.083 ± 23.907 0.38591 
Mean Sleep Bout 
Length 
0.512 ± 1.145 0.562 ± 1.322 0.48803 
Fragmentation Index 5.818 ± 2.804 5.879 ± 2.867 0.479399 
Sleep % 45.15 ± 19.67 45.44 ± 19.75 0.42074 
Total Wake Duration 19.20 ± 6.886 19.096 ± 6.913 0.42074 
Number of Wake 
Bouts 
75.833 ± 22.894  77.083 ± 23.907 0.15386 
Mean Wake Bout 
Length 
0.249 ± 0.043 0.245 ± 0.043 0.405876 
Wake % 54.845 ± 19.674 54.560 ± 19.753 0.42074 














Zebrafish Sleep Variables for High Fat Diet Sleep Analysis 
 
 
Sleep Variables for Control Diet vs. High Fat Diet Trial 1 Groups 
 
Sleep Variable Control Diet (n=12) High Fat Diet (n=4) p-value 
Total Sleep Duration 15.989 ± 6.866 13.954 ± 3.606 0.292666 
Number of Sleep 
Bouts 
76.583 ± 23.57 84 ± 11.165 0.715805 
Mean Sleep Bout 
Length 
0.473 ± 1.014 0.172 ± 0.067 0.683516 
Fragmentation Index 5.869 ± 2.858 6.446 ± 2.294 0.683516 
Sleep % 45.68 ± 19.62 39.87 ± 10.3 0.952747 
Total Wake Duration 19.011 ± 6.866 21.046 ± 3.606 0.292666 
Number of Wake 
Bouts 
77.583 ± 23.57 85 ± 11.165 0.715805 
Mean Wake Bout 
Length 
0.240 ± 0.045 0.247 ± 0.019 0.394092 
Wake % 54.31 ±19.62 60.13 ± 10.3 0.292668 











List of Primers for qPCR 
 
GAPDH: 
Forward: 5’- TGG GCC CAT GAA AGG AAT -3’ 
Reverse: 5’- ACC AGC GTC AAA GAT GGA TG -3’ 
 
TNF-ɑ: 
Forward: 5’- CGC ATT TCA CAA GGC AAT TT -3’ 
Reverse: 5’-CTG GTC CTG GTC ATC TCT CC -3’ 
 
IL-1𝛃: 
Forward: 5’- GTC ACA CTG AGA GCC GGA AG -3’ 
Reverse: 5’- TGG AGA TTC CCA AAC ACA CA -3’ 
 
IL-6 
Forward: 5’- CTG GTA GCC GAG AGG GGA A-3’ 








Single Fish Ct, ΔCt, ΔΔCt, and Fold Change qPCR Values for Infected qPCR Trials 1 
and 2 
 
Single Fish Average Ct Values, ∆Ct Values, ∆∆Ct Values, and Fold Change for 
























IA1 /, 19.13 19.14 N/A   
 IB2 21.5, 20.95 21.225 N/A   
 IC4 27.66, 21.01*  N/A   
 MA3 20.51, 17.35 18.93 N/A   
 MC2 17.14, 17.02 17.06 N/A   
 MC3 18.82, 18.9 18.86 N/A   
TNF-ɑ IA1 /, /     
 IB2 34.57, 31.9 33.235 12.01 -1.867 3.647 
 IC4 31.37, 31.66 31.515**    
 MA3 31.06, 31.34 31.2 12.27   
 MC2 32.18, 31.4 31.79 14.73   
 MC3 32.73, 34.25 33.49 14.63   
IL-1β IA1 26.81, / 26.81 7.37 2.203 0.217 
 IB2 /, 24.25 24.25 3.025 -2.142 4.413 
 IC4 23.89, 23.99 23.94**    
 MA3 23.42, 23.75 23.585 4.655   
 MC2 24.57, 25.16 24.865 7.805   
 MC3 21.75, 22.05 21.9 3.04   
IL-6 IA1 26.23, 27.22 28.725 7.585 -4.638 24.890 
 IB2 24.54, 25.14 24.84 3.615 -8.608 390.046 
 IC4 29.51, 28.51 58.02**    
 MA3 22.57, 36.3*     
 MC2 34.12, 33.21 33.665 16.605   




Note. Single Fish IDs beginning with ‘I’ indicate Active Candida Infection, Single Fish 
IDs beginning with ‘M’ indicate Mock PBS Injection, ‘/’ indicates that no readout was 
provided, ‘*’ indicates that significant variation occurred between duplicate Ct Values 
such that Average Ct Values were not determined, ‘**’ indicates that experimental error 










Single Fish Average Ct Values, ∆Ct Values, ∆∆Ct Values, and Fold Change for 


























21.87, 21.87 21.87 N/A   
 IB1 23.19, 23.74 23.46 N/A   
 MA2 21.47, 21.57 21.52 N/A   
 MB1 26.27, 26.38 21.87 N/A   
TNF-ɑ IA1 37.13, 38.29 37.71 15.84 -0.58 1.495 
 IB1 38.89, 37.52 38.2 14.74 -1.68 3.204 
 MA2 /, 37.94 37.94 16.42   
 MB1 /, / N/A N/A   
IL-1β IA1 29, 28.75 28.88 7.01 2.64 0.160 
 IB1 27.74, 27.47 27.6 4.14 -0.23 1.172 
 MA2 27.61, 26.97 27.29 5.77   
 MB1 28.79, 29.82 29.3 2.97   
IL-6 IA1 35.28, 34.34 34.81 12.94 0.005 0.997 
 IB1 33.97, 33.43 33.7 10.24 -2.695 6.476 
 MA2 35.87, 35.31 35.59 14.07   
 MB1 39.09, 37.17 38.13 11.8   
Note. Single Fish IDs beginning with ‘I’ indicate Active Candida Infection, Single Fish 
IDs beginning with ‘M’ indicate Mock PBS Injection, ‘/’ indicates that no readout was 
provided, ‘*’ indicates that significant variation occurred between duplicate Ct Values 
such that Average Ct Values were not determined, ‘**’ indicates that experimental error 










Single Fish Ct, ΔCt, ΔΔCt, and Fold Change qPCR Values for High Fat Diet qPCR Trials 
1 and 2 
 
Single Fish Average Ct Values, ∆Ct Values, ∆∆Ct Values, and Fold Change for 
























CB1 17.69, 17.35 17.52 N/A 
 
  
 CB2 16.59, 16.9 16.745 N/A   
 CB3 20.77, 20.63 20.7 N/A   
 CB4 23.2, 23.28 23.2 N/A   
 HB2 22.78, 22.8 22.78 N/A   
 HB3 17.18, 17.49 17.335 N/A   
 HB4 16.67, 16.68 16.675 N/A   
TNF-ɑ CB1 32.21, 30.37 31.29 13.77   
 CB2 30.82, 30.96 30.89 14.145   
 CB3 33.88, 34.14 34.01 13.31   
 CB4 35.08, 35.51 35.295 12.095   
 HB2 34.5, 34.75 34.625 11.845 -1.485 2.799 
 HB3 31.75, 31.65 31.7 14.365 1.035 0.488 
 HB4 31.39, 30.22 30.805 14.13 0.8 0.574 
IL-1β CB1 23.17, 22.78 22.975 5.455   
 CB2 22.02, 21.81 21.915 5.17   
 CB3 22.97, 22.63 22.8 2.1   
 CB4 24.04, 24.09 24.065 0.865   
 HB2 22.9, 22.85 22.875 0.095 -3.303 9.866 
 HB3 24, 24.28 24.14 6.805 3.408 0.094 
 HB4 23.68, 23.4 23.54 6.865 3.468 0.090 
IL-6 CB1 34.29, 31.63 32.96 15.44   
 CB2 29.51, 26.6 28.055 11.31   
 CB3 26.79, 26.6 26.695 5.995   




Table continued  
 
 
HB2 27.23, 27.78 27.505 4.725 -4.693 25.880 
 HB3 24.11, 25.84 24.975 7.64 -1.779 3.431 
 HB4 25.99, 23.97 24.98 8.305 -1.114 2.164 
Note. Single Fish IDs beginning with ‘C’ indicate Control Diet, Single Fish IDs 
beginning with ‘H’ indicate High Fat Diet, ‘/’ indicates that no readout was provided, ‘*’ 
indicates that significant variation occurred between duplicate Ct Values such that 
Average Ct Values were not determined, ‘**’ indicates that experimental error occurred 







Single Fish Average Ct Values, ∆Ct Values, ∆∆Ct Values, and Fold Change for 
























CB1 22.93, 21.14 22.035 N/A   
 CB2 19.75, 20.09 19.92 N/A   
 CB3 20.01, 19.4 19.705 N/A   
 CB4 19.3, 18.78 19.3 N/A   
 HB4 17.65, 17.3 17.65 N/A   
 HC1 17.44, 17.4 17.42 N/A   
 HC2 16.85,17.04 16.945 N/A   
TNF-ɑ CB1 33.03, 33.25 33.14 11.105   
 CB2 33.06, 32.91 32.985 13.605   
 CB3 34.72, 37.36 36.04 16.335   
 CB4 32.37, 32.1 32.235 12.945   
 HB4 30.81, 30.73 30.77 13.12 -0.24 1.181 
 HC1 30.99, 31.96 31.475 14.055 0.695 0.618 
 HC2 30.27, 30.76 30.515 13.57 0.21 0.865 
IL-1β CB1 27.58, 30.23 28.905 6.87   
 CB2 32.08, 27.56 29.82 9.9   
 CB3 30.17, 28.05 29.11 9.405   
 CB4 27.05, 26.29 26.67 7.37   
 HB4 24.04, 24.01 24.025 6.375 -2.011 4.031 
 HC1 24.35, 24.47 24.41 6.99 -1.400 2.632 
 HC2 23.56, 23.35 23.455 6.51 -1.876 3.671 
IL-6 CB1 32.72, 34.1 33.41 11.375   
 CB2 31.33, 29.55 30.44 10.52   
 CB3 30.84, 27.75 29.295 9.59   
 CB4 24.86, 24.33 24.595 5.295   
 HB4 24.03, 23.2 23.615 5.965 -3.23 9.383 
 HC1 23.11, 24.2 23.655 6.235 -2.96 7.781 
 HC2 24.11, 22.6 23.55 6.41 -2.785 6.892 
Note. Single Fish IDs beginning with ‘C’ indicate Control Diet, Single Fish IDs 
beginning with ‘H’ indicate High Fat Diet, ‘/’ indicates that no readout was provided, ‘*’ 
indicates that significant variation occurred between duplicate Ct Values such that 
Average Ct Values were not determined, ‘**’ indicates that experimental error occurred 






Whole-study Zebrafish Sleep Variable Summary 
 
Single fish sleep variables for infected analysis group (Trials 1-6) and diet analysis 
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